CN102939537A - Yeast cell wall components and detection thereof - Google Patents
Yeast cell wall components and detection thereof Download PDFInfo
- Publication number
- CN102939537A CN102939537A CN2011800292362A CN201180029236A CN102939537A CN 102939537 A CN102939537 A CN 102939537A CN 2011800292362 A CN2011800292362 A CN 2011800292362A CN 201180029236 A CN201180029236 A CN 201180029236A CN 102939537 A CN102939537 A CN 102939537A
- Authority
- CN
- China
- Prior art keywords
- antibody
- sample
- feed
- cell wall
- callose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
- G01N2333/395—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Saccharomyces
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
- G01N2400/14—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
- G01N2400/24—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to animal feed additives and detection thereof in feed products. Additionally, the present invention relates to yeast cell wall components, their methods of isolation, and compositions and methods for the immunological detection thereof.
Description
Present patent application requires the right of priority of the U.S. Provisional Patent Application sequence number 61/334,995 of submission on May 14th, 2010, and this patented claim is incorporated into way of reference in full accordingly.
Invention field
The present invention relates to animal feed additive and the detection in feed product thereof.In addition, the composition and the method that the present invention relates to yeast cell wall fraction, its separation method and be used for its immunology detection.
Background of invention
In the Animal nutrition field, adopted multiple additives and replenishers to improve the livestock performance.In some cases, yeast cell wall fraction can be used as animal feed additive.An example is feed addictive MYCOSORB (by ALLTECH, Inc. makes).MYCOSORB is in conjunction with the mycotoxin pollutant in the food and feed, thereby with the state isolation of mycotoxin not digesting.This mycotoxin pollutant is usually owing to producing as field in cereal, cereal byproduct and the corn Silage of feed component and harvested conk.Although commercially available feedstuff and feed product component must be through mycotoxin monitorings, it is 100% effective not having monitoring system.According to estimates, about 25% of all crops is subject to mycotoxin pollution affection (Council for Agricultural Science and Technology (1989) " Mycotoxins:Economics and Health Risks " in the world wide, Task Force Report No.116, Ames, therefore IA), the generation that enters the situation of livestock and companion animals supply of forage chain of contaminated material almost is inevitable.The consequence that livestock consumes the feed that mycotoxin pollutes comprises that appetite descends, growth slows down, reproductive function and milk production reduces, immune system is subjected to suppress, digestive function is impaired and dead in severe case.Therefore, the mycotoxin isolation has been proved to be the available strategy for reducing the harm of the naturally occurring toxin that adversely affects animal and human's class health.
Be used for quantitative and qualitative analysis and detect the sane and special analytical approach of feed addictive and the exploitation of kit, the complicated because the relative low concentration of the feed addictive that uses in the feed of animals consuming is supplied with in the existence of a lot of interfering compounds and preparing.
Summary of the invention
The present invention relates to animal feed additive and the detection in feed product thereof.In addition, the composition and the method that the present invention relates to yeast cell wall fraction, its separation method and be used for its immunology detection.The method of the middle yeast cell wall fraction of test sample (for example, Feed Sample, food samples or its extract) and/or its fragment is provided in some embodiments.This method can be used for by yeast cell wall fraction (for example for example determining, yeast dextran, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose, MYCOSORB feed addictive, BIOMOSS feed addictive, ACTIGEN feed addictive etc.) existence of food and feed additive in feed product (for example, animal feeding-stuff, companion animals feed or its preparation intermediate) that consist of.In some embodiments, the present invention relates to for from feed product (for example, animal feeding-stuff, companion animals feed or its preparation intermediate) in extract the method for yeast cell wall fraction (for example, yeast dextran, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose, MYCOSORB feed addictive etc.).In some embodiments, the invention provides the antigen of the antibody that can be used for producing specific yeast cell wall fraction (for example, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose and/or its conjugate).In preferred embodiments, this antigen is conjugated to carrier, for example protein carrier (such as bovine serum albumin(BSA) (BSA)).In some embodiments, the invention provides for C6-OH position activated carbon hydrate (for example, comprise the carbohydrates, glucosan, yeast (1 → 4)-α of glucopyranose ring-/(1 → 6)-callose) method.In some embodiments, this activation comprises mild oxidation (for example, using dimethyl sulfoxide (DMSO)/acetic anhydride).In some embodiments, the invention provides the antibody that can identify yeast cell wall antigen (for example, can identify yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/monoclonal or the polyclonal antibody of (1 → 6)-callose or its conjugate; The monoclonal antibody 513A161.1 that produces for (1 → 4)-α-D-glucosan/(1,6)-callose/BSA antigen or 513A431.1, the polyclonal antibody that produces for (1 → 4)-α-D-glucosan/(1 → 6)-callose/BSA antigen; Or its purifying, dilute, put together and/or monospecific form).In some embodiments, the invention provides and for detection of sample (for example comprise, Feed Sample, food samples or its extract) in the kit of reagent of yeast cell wall fraction (for example, yeast dextran, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose, MYCOSORB feed addictive etc.).
The present invention is not exposed for type or the character restriction of the sample of analysis.In some preferred embodiments, sample is food or feed product or derived from food or feed product.Food or feed product comprise any being consumed (for example, being consumed by animal) and contribute the material of energy and/or nutrition for diet.The example of feedstuff includes but not limited to total mixed ration (TMR), forage, pellet, concentrate, pre-composition secondary product, cereal, vinasse, molasses, fiber, forage grass, herbage, hay, seed (kernal), blade, meal, solvend and replenishers.Feed and feedstuff are not limited by its physical form.Feed and feedstuff can be processed into smaller particle size (for example, chopping, that mince, grind, grind etc.); Make liquid form (for example, extraction, that boil, concentrated, change into slurry or other thickness forms); Or be processed into large-size (for example, bundled, fixed, compression or be configured as compound shape, such as granular, block, square, laminar etc.).
The present invention is not exposed for type or the character restriction of the extracting method that obtains analytic sample.In some embodiments, to original material to be analyzed (for example, food or feed product; Feedstuff) carries out extractive technique to obtain analytic sample.Extractive technique include but not limited to acid extractants, alkali extract, with organic solvent extract, with damping fluid extract, with salt extract, with washing agent extract, physics extracts (for example, boil, steam extraction, low temperature extraction, grinding etc.) or its combination.In some embodiments, with an organic solvent extract material to be analyzed (for example, food or feed product with the combination of acid solution; Feedstuff).In some embodiments, use the solution of dimethyl sulfoxide (DMSO) (DMSO) and hydrochloric acid (HCl) to extract material to be analyzed (for example, food or feed product; Feedstuff).
The present invention is not present in the amount restriction of analyte in the initial sample (for example, antigen, yeast cell wall fraction, yeast dextran, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose, MYCOSORB feed addictive etc.).The amount of analyte can be less than 0.005mg, 0.005-0.05mg, 0.05-0.5mg, 0.5-1mg, 1-5mg, 5-10mg, 10-25mg, 25mg or more.The present invention is not present in the amount restriction of analyte in the initial detected materials (for example, antigen, yeast cell wall fraction, yeast dextran, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose, MYCOSORB feed addictive etc.).The amount of the analyte that detects can be less than 0.05 kg/ton, 0.05-0.5 kg/ton, 0.5-1 kg/ton, 1.0-2.0 kg/ton, 2.0-3.0 kg/ton, 3.0-4.0 kg/ton, 4.0-5.0 kg/ton, 5.0-6.0 kg/ton, 6.0-10.0 kg/ton, 10 kg/ton or more.
The present invention be not exposed for detect analyte (for example, as antigen, yeast cell wall fraction, yeast dextran, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose, MYCOSORB feed addictive etc.) the working concentration restriction of antibody.Antibody (for example, can identify yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast 1 → 4)-α-/monoclonal or the polyclonal antibody of (1 → 6)-callose or its conjugate; The monoclonal antibody 513A161.1 that produces for (1 → 4)-α-D-glucosan/(1 → 6)-callose/BSA antigen or 513A431.1, the polyclonal antibody that produces for (1 → 4)-α-D-glucosan/(1 → 6)-callose/BSA antigen; Or its purifying, dilute, put together and/or monospecific form) working dilution can be than 1: 100,000 is rare; 1: 50,000 to 1: 100,000; 1: 20,000 to 1: 50,000; 1: 10,000 to 1: 20,000; 1: 5,000 to 1: 10,000; 1: 1,000 to 1: 5,000; 1: 500 to 1: 1,000; 1: 100 to 1: 500; 1: 50 to 1: 100; 1: 10-1: 50; 1: 1 to 1: 10; 2: 1 to 1: 1; Or denseer than 2: 1.
In some embodiments, the invention provides the immunogenic composition that comprises yeast cell wall fraction.In some embodiments, yeast cell wall fraction comprises yeast dextran.In some embodiments, glucosan comprise yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose or its conjugate or derivant.In some embodiments, the invention provides the yeast (1 → 6) that is conjugated to carrier (for example, protein carrier)-callose, yeast (1 → 4)-α-/(1 → 6)-callose.Carrier can be conducive to immunogenicity and/or the stability of host animal.The example of carrier includes but not limited to bovine serum albumin(BSA) (BSA), keyhole relative hemocyanin (KLH), ovalbumin (OVA), bovine thyroglobulin (THY) and DHBeAg (DHBcAg) (Gathuru etc. (2005) Vaccine 23:4727-4733).The present invention is not limited by the link position between antigen and the carrier.In some preferred embodiments, antigen (for example, Carbohydrate Antigens, glucosan, the carbohydrates that comprises the glucopyranose ring, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose) is conjugated to carrier in one or more O-6 positions with respect to antigen.In some embodiments, described antigen for the yeast (1 → 4) that is conjugated to BSA in the C6 position-α-/(1 → 6)-callose.
Antibody of the present invention is not limited by its host species that produces therein.Host species can be rat, mouse, cavy, hamster, rabbit, goat, sheep, chicken, donkey, horse, bovid, canid, cats, porcine animals, anthropoid cape, the mankind or any other species.Antibody of the present invention is not exposed for vaccination regimen, antigen preparation method or the restriction of antigen delivery method that produces antibody.Antigen can exist in the situation that has or do not exist immunostimulant (for example, adjuvant), damping fluid, salt, solvent, solubilize compound etc.Can use antigen immune once host species; Twice; Three times; Four times; Five times; 5-10 time; 10-20 time; Or above 20 times.Not clone property (for example, monoclonal, polyclone) restriction of antibody of the present invention.Antibody can rough or purified form use.Antibody can be polyspecific or monospecific.In preferred embodiments, antibody can specific recognition for generation of the antigen of antibody.In some preferred embodiments, (1 → 4)-α that antibody of the present invention can specific recognition extracts from yeast (for example, saccharomyces cerevisiae (Saccharomyces cerevisiae)) cell membrane-D-glucosan/(1 → 6)-callose.In some preferred embodiments, antibody of the present invention comprises polyclonal antibody.In some embodiments, the invention provides can identify yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/monoclonal or the polyclonal antibody of (1 → 6)-callose or its fragment, variant or conjugate.In some embodiments, antibody compositions combining yeast cell membrane of the present invention (1 → 4)-α-D-glucosan, but not in conjunction with except the part that contains (1 → 4)-α-D-glucosan that exists in the material outside the polymkeric substance that contains yeast cell wall (1 → 4)-α-D-glucosan (for example, yeast cell wall (1 → 4)-α-D-glucosan, yeast cell wall (1 → 4)-α-/(1 → 6)-callose or its fragment, variant or conjugate).In some embodiments, antibody compositions combining yeast cell membrane of the present invention (1 → 6)-callose, but not in conjunction with except the part that contains (1 → 6)-callose that exists in the polymkeric substance that contains yeast cell wall (1 → 6)-callose (for example, yeast cell wall (1 → 6)-callose, yeast cell wall (1 → 4)-α-/(1 → 6)-callose or its fragment, variant or the conjugate) material in addition.In some embodiments, antibody compositions combining yeast cell membrane of the present invention (1 → 4)-α-/(1 → 6)-callose, but not in conjunction with except exist in yeast cell wall (for example, yeast cell wall (1 → 4)-α-/(1 → 6)-callose or its fragment, variant or the conjugate) material in addition contain (1 → 4)-α-/part of (1 → 6)-callose.
Antigen detection methods more of the present invention comprise immunologic detection method.In some preferred embodiments, immunologic detection method comprises ELISA.In certain embodiments, use derived from original material to be analyzed (for example, food or feed product; Feedstuff; Its extract) sample and one-level antibody (for example, can be identified the antibody of yeast cell wall fraction; Can identify the antibody of yeast dextran; Can identify yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose and/or yeast (1 → 4)-α-/antibody of (1 → 6)-callose) carry out ELISA.In some embodiments, antibody is directly connected to the material (for example, color-producing bodies, fluorescent material, radioactive label isotope etc.) that can produce detectable signal.In some embodiments, antibody directly or indirectly can produce reagent (for example, color-producing bodies, fluorescent material, radioactive label, isotope etc.) association of detectable signal with another.
In some embodiments, for detection of sample (for example the invention provides, food or feed product, feedstuff, its extract) in the kit of analyte (for example, antigen, yeast cell wall fraction, yeast dextran, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose and/or yeast (1 → 4)-α-/(1 → 6)-callose).Kit components can include but not limited to reagent, Extraction buffer, solvent, washing agent, sealer, pipe, antibody, reference material, instructions and any combination thereof.
In some embodiments, the invention provides service, wherein to original material to be analyzed (for example, food or feed product, feedstuff, its extract) obtain the information about the concentration of analyte (for example, antigen, yeast cell wall fraction, yeast dextran, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose and/or yeast (1 → 4)-α-/(1 → 6)-callose).In some embodiments, carry out described analysis by end user (for example, peasant household, the livestock owner, livestock management person, stock breeder, the companion animals owner, companion animals supvr, companion animals raiser, animal doctor, feed or food product manufacturer, feed or food product dealer, supervision official).In some embodiments, by the end user (for example, peasant household, the livestock owner, livestock management person, stock breeder, the companion animals owner, companion animals supvr, companion animals raiser, animal doctor, feed or food product manufacturer, feed or food product dealer, supervision official) sample or original material are submitted to the third party, and the third party carries out described analysis.In some embodiments, the third party passes to end user (for example, peasant household, the livestock owner, livestock management person, stock breeder, the companion animals owner, companion animals supvr, companion animals raiser, animal doctor, feed or food product manufacturer, feed or food product dealer, supervision official) with Relevant Analysis result's information.In some embodiments, the third party will pass to the four directions about the information of analysis result.
Based on the instruction that this paper comprises, other embodiments will be apparent for those skilled in the relevant art.
Description of drawings
Fig. 1 illustrates the synoptic diagram (referring to for example embodiment 1) of preparation glucosan fraction P1, P2, P3 and S1, S2 and S3.
Fig. 2 illustrates the response of sero-fast four parts of supernatants of initial rabbit anti-serum and affinity purification.The antiserum of affinity purification obtains (referring to for example embodiment 3) by being separated to the microwell plate that is coated with BSA to special (Gab 1-Gab4) antibody of β-(1,6)-glucosan.
Fig. 3 illustrate use purifying anti--(1 → 4)-α-/calibration curve of (1 → 6)-callose-BSA multi-clone rabbit antibody construction, described antibody uses method as herein described to produce (referring to for example embodiment 2 and 3).
Fig. 4 illustrates and uses that 6 MYCOSORB comprise the average curve that level carries out measuring for 5 times gained in the dairy feed material.The 2nd y-aixs cylinder goes out the in a few days (%CV of display standard curve
In) and (%CV in the daytime
Between) repeated precision.
Fig. 5 illustrates and uses that 6 MYCOSORB comprise the average curve that level carries out measuring for 5 times gained in the chicken feed material.The 2nd y-aixs cylinder goes out the in a few days (%CV of display standard curve
In) and (%CV in the daytime
Between) repeated precision.
Fig. 6 illustrates and uses that 6 MYCOSORB comprise the average curve that level carries out measuring for 5 times gained in the pig feed material.The 2nd y-aixs cylinder goes out the in a few days (%CV of display standard curve
In) and (%CV in the daytime
Between) repeated precision.
Fig. 7 illustrates average optical reading (the Δ OD that distributes the interference product of the MYCOSORB product signal deduction that obtains for a plurality of microtiter plates from the chicken feed
450) difference (embodiment 7).Except the MYCOSORB product (100%, 1.0kg/T) outside, add to disturb product with 50%, 100%, 200% (w/w).
Fig. 8 illustrates average optical reading (the Δ OD that distributes the interference product of the MYCOSORB product signal deduction that obtains for single microtiter plate from the chicken feed
450) difference (embodiment 7).Except the MYCOSORB product (100%, 1.0kg/T) outside, add to disturb product with 50%, 100%, 200% (w/w).
It is the ELISA measurement result of cross reactivity of the monoclonal antibody 513A161.1 of 1: 100 (top) or 1: 200 (bottom) that Fig. 9 illustrates indication concentration.
It is the ELISA measurement result of cross reactivity of the monoclonal antibody 513A161.1 of 1: 500 (top) or 1: 1000 (bottom) that Figure 10 illustrates indication concentration.
It is the ELISA measurement result of cross reactivity of the monoclonal antibody 513A161.1 of 1: 1500 (top) or 1: 2000 (bottom) that Figure 11 illustrates indication concentration.
It is the ELISA measurement result of cross reactivity of the monoclonal antibody 513A431.1 of 1: 100 (top) or 1: 200 (bottom) that Figure 12 illustrates indication concentration.
It is the ELISA measurement result of cross reactivity of the monoclonal antibody 513A431.1 of 1: 500 (top) or 1: 1000 (bottom) that Figure 13 illustrates indication concentration.
It is the ELISA measurement result of cross reactivity of the monoclonal antibody 513A431.1 of 1: 1500 (top) or 1: 2000 (bottom) that Figure 14 illustrates indication concentration.
Figure 15 illustrates with undiluted or measure absorbance reading and standard deviation (embodiment 6) by the average ELISA that the form in PBS or the PBS+3% skimmed milk power of being diluted at 1: 1 is fixed to three primary yeast cell wall extracts standard items on the plate.
Figure 16 illustrates the figure for the feed extract typical curve of the ELISA microplate coating time described in the embodiment 6 and incubation temperature.
Definition
In order conveniently to understand the present invention, a plurality of terms and phrase are defined as follows:
As used herein, term " peptide ", " polypeptide " and be connected protein " all refer to the amino acid whose primary sequence that connects by covalency " peptide bonding ".In general, peptide is by several amino acid, common 2-50 Amino acid profile, and lack than protein.Peptides and proteins contained in term " polypeptide ".In some embodiments, peptide, polypeptide or protein synthesize, and in other embodiments, peptide, polypeptide or protein are restructuring or naturally occurring.Synthetic peptide is the peptide (namely not producing in vivo) by external manual method preparation.
Term " glycoprotein " or " glycopeptide " refer to comprise protein or peptide one or more and the carbohydrates residue that polypeptied chain is covalently bound.Term " contains selenoprotein " or " containing the selenium peptide " refers to comprise protein or the peptide of one or more selenium atoms.Usually, selenium atom is incorporated in the protein with the form within containing selenoaminoacid (comprising selenocysteine and selenomethionine).
Term " selenium-containing protein saccharide ", " containing the selenium glycopeptide " or " SGP " refer to mix glycoprotein or the glycopeptide of one or more selenium atoms.Usually, " selenium-containing protein saccharide " comprises one or more selenoaminoacids that contain." selenium-containing protein saccharide " can comprise a plurality of any amount of multi-form carbohydrates that are.
Term " sample " and " sample " are with its most widely implication use and contain sample or the sample that obtains from any source.As used herein, term " sample " is used to refer to the biological sample that obtains from animal (comprising the mankind), and contains fluid, solid, tissue and gas.In some embodiments of the present invention, sample comprise the material that comprises plant origin sample (ensilage, cereal, through the animal feeding-stuff of processing, in the mill between the feed product in stage).Yet these examples should not be construed as the type of the sample that restriction can use with the present invention.
As used herein, term " yeast " and " yeast cells " refer to be sorted in mycota, have cell membrane, the eukaryotic microorganisms of component in cell membrane and the cell.Yeast does not form specific taxonomy or phylogenetic grouping.About 1,500 kind is known at present; According to estimates, only have 1% to be described in all yeast kinds.Term " yeast " often is taken as the synonym of saccharomyces cerevisiae, but the position display of yeast in Ascomycota and two doors of Basidiomycota its Phylogenetic diversity.Brewer's yeast, saccharomyces cerevisiae and Saccharomyces cerevisiae contained in term " yeast ".Budding yeast (" true yeast ") is sorted in Saccharomycetes.Most of yeast kinds are carried out vegetative propagation by sprouting, but some are bred by binary fission.Yeast is single celled, but some sprout cell strings that go out of planting by forming connection become many cells, and the sprout cell string that goes out of described connection is called pseudo-mycelia (pseudohyphae) or pseudohypha (false hyphae).The large I of yeast alters a great deal according to the difference of planting, and diameter is measured as 3-4 μ m usually, but some yeast can reach above 40 μ m.As used herein, term " yeast cell wall " is also referred to as " YCW ", refers to the plasmalemma that centers on yeast of yeast bio body and the cell membrane of the interior component of cell.Yeast cell wall comprises skin (mainly being mannan) and the internal layer (mainly being glucosan and chitin) of yeast cell wall.The effect of cell membrane provides structure and protection yeast inner (its metabolic activity center).Signal conduction and identification path are arranged in yeast cell wall.The composition of yeast cell wall is different and change according to the growth conditions of yeast because of the difference of bacterial strain.
As used herein, term " yeast cell wall extract " refer to through breaking or cracking (for example, break with cleavage stages during) and the yeast cell wall of the yeast that separates with component in the soluble cell of yeast cells.
As used herein, term w/w (w/w) refers to that given material is based on the amount of weighing scale in the composition.For example, the quality that the animal feed that comprises the meals feed additive of the present invention of 0.02%w/w means this meals feed additive be animal feed gross mass 0.02% (for example, 200 grams meals feed additive composition of the present invention in the animal feed of 907,200 grams).
As used herein, term " purifying " or " with purifying " refer to remove some components from sample.For example, come purifying yeast cell membrane or yeast cell wall extract by removing non-yeast cell wall fraction (for example, component in cytoplasma membrane and/or the yeast cells); Also by remove pollutant except yeast cell wall or reagent come purifying they.The pollutant that removes non-yeast cell wall fraction and/or non-yeast cell wall causes yeast cell wall or its component number percent in sample to increase.On molecular level, term " purifying " refers to the molecule (for example, carbohydrates, glycoprotein) that removes, separate or separate from its natural surroundings.Therefore " carbohydrates of separation " can be the carbohydrates of purifying." basically purifying " molecule at least 60%, preferred at least 75%, also more preferably at least 90% do not contain other and its natural relevant component.As used herein, term " purifying " or " with purifying " also refer to remove pollutant from sample.Removing contaminating protein matter causes the polypeptide the paid close attention to number percent in sample to increase.In addition, in plant, bacterium, yeast or mammalian host cell, express and come purified polypeptide from purification of Recombinant polypeptide (for example, glycoprotein) wherein and by removing host cell proteins matter; The number percent of recombinant polypeptide in sample increases thus.As used herein, term " animal " refers to belong to those of the animal kingdom.This includes but not limited to livestock, farm-animals, domestic animal, companion animals or pet, ocean and fresh water animals and wild animal.
As used herein, term " livestock " is also referred to as " livestock kind ", also be called " cattle ", be called again " commercial letting animals feed ", refer to be intended under agricultural or the aquatic products industry environment to cultivate to produce food or fiber or in order to obtain the performing animal of its labour or company.
As used herein, term " dietary supplement ingredient " " dietary supplements " " dietary supplement composition " etc. refers to be mixed with the meals of part as the diet additive of animal feed (for example, as) or the food product of nutritious supplementary pharmaceutical.This paper describes exemplary dietary supplement composition.
As used herein, term " kit " is used in reference to the combination of reagent and other materials.Be envisioned that kit can comprise such as the reagent that extracts solution, antibody and detection reagent.Term " kit " is not intended to be limited to the particular combinations of reagent and/or other materials.
As used herein, term " toxicity " refers to any unfavorable or harmful effect of comparing object, cell or tissue with same cell before using Toxic or tissue.
As used herein, term " freeze drying " and term " freeze-drying " and term " cold doing " refer to remove solvent by distillation from the material that is frozen state.Then this by providing latent heat of sublimation to realize to it with material to be dried is freezing below the eutectic point.Accurate control to the heat input allows can not make the product melt back from the frozen state drying.In actual applications, under reduced pressure, accelerate and accurately control this process.
As used herein, term " flows freely dry powder " and refers to free-pouring dry powder, such as toppling over from container, bag, vessel etc. and there is not the powder of the obstruction of bulk.
As used herein, term " grinding " refers to reduce granularity by impacting, shear or rubbing.
As used herein, term " washing " (for example refers to, (for example use the solute of any type, distilled water, damping fluid or solvent) or potpourri) impurity or the unwanted soluble component that remove or wash down prepared product (for example, can wash yeast cell wall extract to remove non-yeast cell wall fraction from sample; Can wash the hole of microtiter plate to remove the component of non-binding or non-specific binding).
Term " antibody " or " immunoglobulin (Ig) " refer to the protein of binding specificity antigen.Immunoglobulin (Ig) includes but not limited to polyclone, monoclonal, chimeric and humanized antibody, Fab fragment, F (ab ')
2Fragment, and comprise the immunoglobulin (Ig) of following classification: IgG, IgA, IgM, IgD, IbE and S-IgA (sIg).Immunoglobulin (Ig) has two identical heavy chains and two light chains usually.Yet term " antibody " and " immunoglobulin (Ig) " are also contained single-chain antibody and double-chain antibody.Can be by any known method Dispersal risk (referring to for example Current Protocols in Immunology (1998) John Wiley and Sons, Inc., N.Y.).
Term " antigen " refer to can with carbohydrates, protein, glycoprotein, lipoprotein, lipid or other materials to the special antibody response of the part of antigen molecule.
As used herein, term " analyte " refers to grouping, material or the chemical constitution of atom, molecule, atom and/or molecule.Analyte itself can not be measured, and aspect or the character (physics, chemistry, biology etc.) of opposite analyte can be used such as HPLC or NMR routine analyzer and measure.For example, can not measure " chair " (analyte component) itself, but height of chair, width etc. can be measured.Equally, mycotoxin can not be measured, but mycotoxin signal concentration dependent with it (for example, add lustre to signal, fluorescence signal) can be measured.
Term " immunoprecipitation ", " Immunological purification " and " affinity purification " and such as verb and adjectival grammatical variants form refer to use antibody that the part of its antigen or its antigen is separated with the potpourri of other molecules.
Term " immune detection " and grammatical variants form refer to use antibody to differentiate the existence of antigen or its part from the potpourri of other molecules.
Term " dyeing " refers to that known being used for of those skilled in the art manifests better, distinguishes or the specific components of expert evidence (for example, the extract of sample, Feed Sample, Feed Sample, cell, cell) and/or a lot of methods of feature.
Term " immunofluorescence " refers to for implementing personnel known program evaluation, mark by this area, indicating, manifest or make the staining technique that is easy to see, wherein part (being generally antibody) and acceptor (being generally antigen) in conjunction with and this part, if be antibody, then be conjugated to fluorescence molecule, or this part is then by the antibody combination special to this part, and described antibody is conjugated to fluorescence molecule, wherein said fluorescence molecule can use suitable instrument (for example, fluorescent microscope) to manifest.
Term " antigenic determinant " refers to the part that contacts with specific antibodies (for example, epi-position) of antigen.When protein or protein fragments are used for immune host animal, a plurality of zones of protein can cause produce with protein on the given area or the antibody of three-dimensional structure specific binding; These zones or structure are called antigenic determinant.Antigenic determinant can be combined with antibody with complete antigen (being used for causing " immunogene " of immune response) competition.
As used herein, term " immunoassays " refers to be intended to allow the qualitative or quantitative test of antigen in the test sample.Immunoassays utilize antigen recognizing antibody usually.Antigen recognizing antibody can directly or indirectly be coupled to the visualization step, for example adds lustre to or fluorescence labeling or enzyme.The example of immunoassays includes but not limited to enzyme linked immunosorbent assay (ELISA) (" ELISA "), lateral chromatography test, Western blotting, based on mensuration (for example, the Luminex of particulate
Mensuration), magnetic immunoassay, Dot blot, enzyme immunoassay (EIA) (EIA), radioimmunoassay (RIA), chemiluminescent immunoassay(CLIA) (CLIA), counting immunoassays (CIA) etc.Immunoassays can be competitive or noncompetitive.
As used herein, term " enzyme linked immunosorbent assay (ELISA) " or " ELISA " are sometimes referred to as " sandwich assay ", refer to a kind of immunoassays of particular type.Usually, with the absorption of the antigen of unknown quantity or be fixed on the solid surface and be exposed to the antibody that to identify it.Usually by directly or indirectly being connected to fluorescence or the enzyme that adds lustre to is measured the quantity of the antibody of combination.The type of ELISA includes but not limited to Salmonella, indirect ELISA, sandwich ELISA, competitive ELISA and reverse ELISA.As used herein, term " ELISA " refers to enzyme linked immunosorbent assay (ELISA) (or EIA).Multiple ELISA methods and applications are known in the art, and be described in a lot of lists of references (referring to for example Crowther, among the Molecular Biomethods Handbook " Enzyme-Linked Immunosorbent Assay (ELISA) ", Rapley etc. (editor), the 595-617 page or leaf, Humana Press, Inc., Totowa, N.J. (1998); Harlow and Lane (editor), Antibodies:A Laboratory Manual, Cold Spring Harbor Laboratory Press (1988); Ausubel etc. (editor), Current Protocols in Molecular Biology, Chapter 11, John Wiley ﹠amp; Sons, Inc., New York (1994)).In addition, there is multiple commercially available ELISA test system.As used herein, term " food ", " foodstuff ", " feed ", " feed product ", " feedstuff " etc. refer to any being consumed (for example, being consumed by animal) and contribute the material of energy and/or nutrition for diet.Example includes but not limited to total mixed ration (TMR), forage, pellet, concentrate, pre-composition secondary product, cereal, vinasse, molasses, fiber, forage grass, herbage, hay, seed, blade, meal, solvend and replenishers.Feedstuff is not limited by its physical form.Feedstuff can be processed into smaller particle size (for example, chopping, that mince, grind, grind etc.); Make liquid form (for example, extraction, that boil, concentrated, change into slurry or other thickness forms); Or be processed into large-size (for example, bundled, fixed, compression or be configured as compound shape, such as granular, block, square, laminar etc.).
As used herein, when when the noun, " adjuvant " or " replenishers " refers to add to or otherwise covers material or the things in another material or the things.In addition, as used herein, when when the noun, word " adjuvant " or " replenishers " are used interchangeably when mentioning " adjuvant " or " replenishers " that is mixed into before being supplied to animal in the animal feed.
As used herein, term " glucosan " refers to any carbohydrate polymer that contains glucose.In some embodiments, glucosan is the polymkeric substance of D-Glucose, and its degree of polymerization without limits, covalently or non-covalently be connected or definite carbohydrate composition with other polymkeric substance.On the whole length of dextran polymer, the D-Glucose unit can participate in two kinds of α-bonding, β-bonding or α-bonding and β-bondings.
As used herein, term " carbohydrates " is used in reference to has general formula C
m(H
2O)
nOrganic compound.Carbohydrates only is comprised of carbon, hydrogen and oxygen atom, thereby the atomic ratio of hydrogen atom and oxygen atom is 2: 1.
As used herein, term " signal " is generally used for referring to that any detectable Indicator Reaction carries out the process of (for example, antibody is combined with antigen).It is contemplated that the signal that is product radioactivity, fluorescence or colorimetric/reagent form will all can use with the present invention.In a plurality of embodiments of the present invention, signal is carried out qualitative evaluation, and in alternate embodiment, signal is carried out qualitative assessment.
As used herein, term " solid phase support thing " is used in reference to such as the reagent of antibody, antigen and attached any solid or the immobilization material of other fractions tested.For example, in the ELISA method, the hole of microtiter plate provides the solid phase support thing.Other examples of solid phase support thing comprise microslide, cover glass, globule, particle, Tissue Culture Flask and a lot of other suitable article.
Term " specific bond " and " specific binding " are described the interaction of the existence that depends on the ad hoc structure (being antigenic determinant or epi-position) on the antigen when the interaction that is used in reference between antibody and the antigen.In other words, the distinctive protein structure of antibody recognition and conjugated antigen, rather than in conjunction with all proteins (being non-specific binding) substantially.
Detailed Description Of The Invention
Yeast cell wall (YCW) has the labyrinth that comprises two kinds of main polysaccharide components: (1 → 2) (1 → 3) (1 → 6)-α-D-mannan and (1 → 3) (1 → 6)-callose.These polysaccharide are connected with YCW protein with the N-glycosidic bond by the O-glycosides key, such as comment (Lesage etc. (2006) Microbiol.Mol.Biol.Rev.70:317-343 of nearest publication; It is incorporated herein by reference in full) the middle discussion.On industrial scale, usually separate or extract YCW from the yeast bio body of cracking by centrifugal and washing, as D.A.Howes and K.E.Newman report (referring to for example U.S. Patent No. 6,045,834; It is incorporated herein by reference in full).At this one-phase, YCW is water insoluble.The structure of the elementary YCW modified polysaccharide of follow-up enzyme and chemical treatment and protein, thereby so that these YCW components at least in part in the water-soluble and dimethyl sulfoxide (DMSO) " DMSO ".The solubility of product and the composition of insoluble part depend on treatment conditions.
Immunoassays comprise the sensitive analysis technology that can use with the potpourri of this complexity, non-homogeneous.In certain methods embodiment of the present invention, control oneself with this polysaccharide of antibody recognition of animal of the antigen immune that comprises yeast (1 → 6)-callose, thereby allow to set up sane and sensitive immunoassays, described yeast (1 → 6)-callose interconnects (referring to (1997) J.Biol.Chem.272:17762-17775 such as Koll á r all primary structure components of cell membrane; It is incorporated herein by reference in full).In some embodiments of the present invention, quantitative immunoassays (ELISA) the nourishing additive agent MYCOSORB (ALLTECH, Inc.) that allows the YCW in the analyzing animal Feed Sample to derive.Very special to the quantitative YCW aspect that is determined at from (1 → 6)-callose of YCW, because (1 → 6)-callose is very rare in plant carbohydrates.Therefore, significantly do not interact with the plant polyose that is present in the animal feed for the antibody of this YCW polysaccharide, thereby guarantee to hang down the mensuration background.
In addition, embodiments more of the present invention also are provided for following method: 1) from yeast cell wall separate solubility (1 → 4)-α-/(1 → 6)-callose is (referring to (2002) Yeast 19:131-139 such as (2009) J.Instit.Brew.115:1031 such as Kwiatkowski and Arvindekar, all be incorporated herein by reference in full separately), for example as for the preparation of identification yeast (1 → 4)-α-/antigen of the antibody of (1 → 6)-callose; Use Pfizner-Moffat reagent (referring to (1963) J.Am.Chem.Soc.85:3027 such as Pfizner; It is incorporated herein by reference in full) oh group of the glucopyranose ring C-6 position of this polysaccharide of oxidation, in order to convert it into aldehyde radical (referring to (2006) Chem.Papers60:243-248 such as Zekovic; It is incorporated herein by reference in full); And with (1 → the 4)-α of this oxidised form-/(1 → 6)-callose is used for reductive amination process with the lysine residue of bovine serum albumin(BSA) (BSA) (referring to (1996) J.Org.Chem.61:3849-3862 such as Abdel-Magid; It is incorporated herein by reference in full), thus polysaccharide-protein conjugate produced.In some embodiments, the invention provides for separating of and purifying (for example, use the Na of ion-exchange, DEAE cellulose and different ionic strength
2HPO
4Damping fluid) (1 → 4)-α-/method of (1 → 6)-callose-BSA conjugate, described (1 → 4)-α-/(1 → 6)-callose-BSA conjugate is used as solubility immunogene in animal (such as the rabbit) immunity (referring to (2001) Basic Methods in AntibodyProduction and Characterization such as Howard, CRC Press, 11-18 and 31-50 page or leaf).In some embodiments, the preparation method (referring to Matejtschuk (1997) Affinity Separations:a Practical Approach, Oxford University Press) who the invention provides the affine phase resin that BSA-applies with and from comprise the antibody special to BSA and to (1 → 4)-α-/rabbit anteserum of the special antibody of (1 → 6)-callose absorption to the purposes of the special antibody of BSA.In some embodiments of the present invention, be used for that polysaccharide is conjugated to method of protein and can be used for preparing human and animal's vaccine, because this method has kept the initial configuration of polysaccharide and modified its reducing end (referring to U.S. Patent No. 6,596,861 unlike common conjugation methods; It is incorporated herein by reference in full).
Brewing yeast cell wall glucosan
Glucosan is general (referring to (2009) J.Instit.Brew.115:151-158 such as Kwiatkowski) in brewing yeast cell wall polysaccharide.There is document to record the effect of (1 → 3)-callose in keeping yeast cell wall shape and rigidity (referring to (2006) Yeast23:185-202 such as Klis; Lesage etc. (2006) Microbiol.Mol.Biol.Rev.70:317-343; All be incorporated herein by reference in full separately) and (1 → 6)-callose as the effect of the polysaccharide that all cells wall polysaccharide is linked together (referring to (2009) J.Biol.Chem.284:13401-13412 such as Aimaniada; (1997) J.Biol.Chem.272:17762-1777 such as Koll á r; Klis etc. (2002) FEMS Microbiology Rev.26:239-256; All be incorporated herein by reference in full separately).The yeast document is (referring to (1974) Biochem.Biophys.Res.Com.56:588-592 such as Gunja-Smith in early days; Grba etc. (1975) Appl.Microbiol.Biotechnol.2:29-37; All be incorporated herein by reference in full separately) in frequently mention the existence of solubility and insoluble glycogen sample (1 → 4)-alpha-D-glucose in the brewing yeast cell of grow aerobically, and the glycogen synthetase of having identified two kinds of forms is (referring to (1977) J.Bacteriol.130:818-825 such as Gunja-Smith; Rothman-Denes etc. (1970) PNAS 66:967-974; All be incorporated herein by reference in full separately).Glycogen is the energy reserve carbohydrates by the saccharomyces cerevisiae accumulation, and it can be employed during the hungry stage of yeast.It is the polymkeric substance of alpha-D-glucose, and its molecular weight is~10
8And its branched structure has the residue of 10-14 the alpha-D-glucose that connects by 1 → 4 bonding (referring to (2008) J.Instit.Brew.114:205-208 such as Aklujkar; Boulton etc. (2001) The Biochemistry of Fermentation.In:Brewing Yeast and Fermentation, Blackwell Science, Iowa, 89-92 page or leaf; All be incorporated herein by reference in full separately).
In the yeast cell wall (1 → 4)-α-D-beta-dextran content can from few 1% (referring to (1980) J.Bacteriol.143:1384-1394 such as Lille) to dry weight change to dry weight nearly 29% (referring to Sedmak etc., U.S. Patent application No.2006/0263415; It is incorporated herein by reference in full), depend on time (referring to (1980) J.Bacteriol.143:1384-1394 such as Lille) of nutritional status, separation method, environmental baseline and the harvesting of cell.The beer yeast cells of industrial generation is (referring to Sedmak etc., U.S. Patent application No.2006/0263415; It is incorporated herein by reference in full) comprise the glucosan of 28.9% dry weight (d.w.) concentration, it comprises (1 → 4)-α of 12.4%d.w.-D-glucosan.When using alkali protease to process these cells, water-insoluble cell-wall components comprises the glucosan of 54.5%d.w. and surpasses half (1 → 4)-α-D-glucosan (29.2%d.w.) of this weight.
In 2002, Arvindekar and Patil were (referring to (2002) Yeast 19:131-139 such as Arvindekar; It is incorporated herein by reference in full) based on its following discovery: (1 → 4)-α-D-glucosan is covalently bound with (1 → 6)-callose, has proposed to be defined as " being difficult to wash away " yeast glycogen by other people (referring to (1976) J.Gen.Microbiol.94:180-192 such as Fleet about existing in the yeast cell wall; It is incorporated herein by reference in full) the explanation of insoluble part.Yet 1997 papers that this and Kollar and co-worker deliver are (referring to (1997) J.Biol.Chem.272:17762-17775 such as Koll á r; It is incorporated herein by reference in full) and with Aimaniada and co-worker deliver about (1 → 6)-callose in yeast cell wall effect and the work of structure (referring to (2009) J.Biol.Chem.184:13401-13412 such as Aimaniada; It is incorporated herein by reference in full) inconsistent.It should be noted that the discovery Structure of need checking of Arvindekar and Patil, study because the author uses from the small fragment of the enzyme hydrolysis of yeast cell wall, and do not use NMR that the product of its separation is carried out quantitatively or the structure ownership.In the experiment of in the process of exploitation embodiment of the present invention, carrying out, develop extensive separation method and mixed (1 → 4)-α-D-glucosan/(1 → 6)-callose polysaccharide to separate from the brewing yeast cell wall, and used nuclear magnetic resonance (NMR) spectroscopic methodology to determine the structure of this product.
Animal food and feed
Animal feed is to be used for especially feeding any foodstuff of raising and train livestock (for example, ox, goat, sheep, horse, poultry, wild ox, alpaca, yamma, donkey, mule, rabbit, chicken, goose, turkey and pig).Animal feed generally includes hay, straw, ensilage, compression and pellet, oils and mixed ration and germinated ceral and beans.Global animal feed industries consumed 63,500 ten thousand tons of feeds in 2006, and annual growth is about 2%.Planting feed rather than human foods with farming land, to can be tool controversial; The feed of some types such as corn (corn) (corn (maize)) also can be used as human foods, and can not such as other feeds of herbage.Except providing energy source to animal, the nutrient (for example, selenium) that animal feed also provides health to utilize.Animal feed (for example, MYCOSORB) mixed with replenishers and/or adjuvant before supplying with animal usually.
Immunologic detection method
The invention provides the method for detection of material in the sample, this method comprises immune detecting measuring or immunoassays.Immunoassays (immune detecting measuring, immunologic detection method) relate to the antibody that uses the material (for example, antigen) of being combined with antibody for detection of (visualization, Qualitative Identification, quantitatively detection).Be can be large molecule or its fragment (for example, polymkeric substance, carbohydrates, glycoprotein, protein, its part or monomer) by the antigen of antibody recognition.For example, certain methods of the present invention can be used for detecting yeast cell wall glucosan (for example, (1 → 4)-α-D-glucosan, (1 → 6)-callose and/or (1 → 4)-α-/(1 → 6)-callose).
Panimmunity measure can be used for qualitative or quantitative detection material (material that for example, exists with low concentration, be present in material in the complex mixture, carbohydrate substance, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose).The type of immunoassays includes but not limited to enzyme linked immunosorbent assay (ELISA) (ELISA), lateral chromatography test, Western blotting, based on mensuration (for example, the Luminex of particulate
Measure), magnetic immunoassay, Dot blot, enzyme immunoassay (EIA) (EIA), radioimmunoassay (RIA), chemiluminescent immunoassay(CLIA) (CLIA), counting immunoassays (CIA) etc. are (referring to such as (2005) such as Wild " The Immunoassay Handbook; the 3rd edition ", Elsevier Ltd., Oxford, UK).Immunoassays can be competitive or noncompetitive.
Enzyme linked immunosorbent assay (ELISA) (ELISA)
Enzyme linked immunosorbent assay (ELISA), " ELISA " is as the diagnostic tool in the quality control check in medical science and Plant Pathology and the every profession and trade.In an example, typical ELISA comprises and at first is fixed on polystyrene microplate or other lip-deep probe molecules.Then apply such as the sealer of BSA and hatch.Biological sample or other samples of the specific target molecules (being generally protein) that comprises unknown concentration are contacted with the probe molecule of fixing.If exist, target molecule is caught by probe, and proportional with the concentration of target molecule.Then, usually using mild detergent solution washing surface is not the molecule of specific binding to remove any.Then, apply the other molecule such as second antibody, thereby form " sandwich " compound of the detector probe with capture probe, target molecule and mark.The second molecule is commonly referred to detector probe or detects antibody, and general and enzyme, haptens or other labeled molecule are covalently bound.
After final washing step, report that by adding be combined and comprise zymolyte, fluorescently-labeled detection reagent or multiple other with the detection antibody of mark the conjugate of things makes the plate development.The proportional detectable signal of amount of target antigen in described report deposits yields and the sample.Usually, use colorimetric or fluorescence to read the plate instrument and read the ELISA reading, and each hole produces the single target analyte measurement.Other variations that ELISA measures include but not limited to indirectly, competitive or reverse ELISA (referring to such as (2008) such as Crowther " The ELISA Guidebook, the 2nd edition ", Humana Press).
Under many circumstances, making for coupling so that can realize that the microplate of the standardized format of processing carries out ELISA by self-reacting device.These standards are set up by biomolecule science association (SBS) and are called as the SBS standard.According to the SBS standard, " areal coverage " of porous plate is about 85mm * 125mm, and its mesopore is with the ad-hoc location formatting according to the hole sum.The SBS standard that ANSI (ANSI) has announced microplate is: " overlay area size " (ANSI/SBS 1-2004), " height dimension " (ANSI/SBS 2-2004), " bottom physical dimension " (ANSI/SBS 3-2004) and " hole dimension " (ANSI/SBS 4-2004).The most common ground, ELISA user adopts the 96-hole in single plate.Alternatively, in measuring, need to be less than the 96-hole, can adopt maximum 12 8-holes " bar " thus so that once only use the part in 96-hole.
Testing service
In some embodiments, with the computer based routine analyzer with mensuration (for example, immunoassays, ELISA) raw data that produces is (for example, the existence of antigen, do not exist or measure) (for example, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose) change into end user (for example, livestock or companion animals raiser or supvr, animal doctor, peasant household, consumer) is had the data of predictive value.The end user can make and access in any suitable manner predicted data.Therefore, in some embodiments, the invention provides further beneficial effect, namely unlikelyly be subjected to the end user of immunoassays analyzing and training not need to understand raw data.Data are directly presented to the end user with its most useful form.Then the end user can utilize this information immediately in order to optimize nursing to object (for example, livestock or companion animals).
The present invention is susceptible to and anyly can receives, process with transmit back and forth the method for the information of relevant sample with the laboratory of measuring.For example, in some embodiments of the present invention, (for example obtain sample, the extract of Feed Sample, Feed Sample) and be submitted to be positioned at the world Anywhere (for example, in the country at object place or finally use the national consistent or different country of information) Analysis Service mechanism (for example, laboratory etc.) with the generation raw data.The end user can allow the third party obtain sample (for example, the feed extract) and be delivered to analytic centre (profiling center), and perhaps object can be collected voluntarily sample and directly it is delivered to analytic centre.When sample comprises the information of determining before this, the end user can directly be delivered to this information Analysis Service mechanism (for example, can comprise the load card of described information and use electronic communication system data to be sent to the computing machine of analytic centre by computer scanning).In case analyzed service organization receives, and just sample is processed and produced required diagnosis or prognosis the characteristics of information figure (for example, antigenic content) specific to the end user.
Then the characteristic pattern data are prepared to and are suitable for the form that the end user understands.For example, and provide raw data opposite, the form of preparation can embody risk assessment (for example, the possibility that antigen exists) to the end user, offers suggestions for specific animal nursing selection simultaneously.Data can show the end user by any suitable method.For example, in some embodiments, Analysis Service mechanism produces and can be the report that the end user prints the report of (for example, in the place of contact, in the place of livestock nursing) or can show at graphoscope the end user.
In some embodiments, at first analyze information in the place of livestock nursing or at regional facility place.Then raw data is delivered to Central Processing Facility further to analyze and/or raw data is changed into the information that end user or other interested related sides can use.Central Processing Facility provides the conforming advantage of privacy (all data all are kept in the central facilities with unified security protocol), speed and data analysis.Then Central Processing Facility with the destiny that can control data after the end user communicates by letter.For example, use electronic communication system, central facilities can offer the end user with data.
In some embodiments, the end user can use the direct visit data of electronic communication system.The end user can seek further suggestion based on the result.In some embodiments, data are used for the research purposes.For example, data can be used for further optimizing the nutritional programs of livestock or companion animals.
Composition and kit
(for example be used for, enough being used for, necessaryly being used for or can be used for) composition of the method for embodiments more of the present invention comprises the existence whether reagent for detection of specific antigen (for example, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose).Appoint whichever in these compositions, separately or with other combination of compositions of the present invention, form that can kit provides.Kit can comprise in addition suitable contrast and/or detect reagent.
Antigen-carrier is puted together
In some embodiments, the invention provides and can be used for analyzing (for example, immune analysis; Be used for the antibody preparation) composition (for example, antigen) of yeast cell wall material.In some embodiments, the invention provides for following method: from yeast cell wall separate solubility (1 → 4)-α-/(1 → 6)-callose is (referring to (2009) J.Instit.Brew.115:1031 such as Kwiatkowski; Arvindekar etc. (2002) Yeast 19:131-139; All be incorporated herein by reference in full separately) as the antigen of yeast (1 → 6)-callose; Use Pfizner-Moffat reagent (referring to (1963) J.Am.Chem.Soc.85:3027 such as Pfizner; It is incorporated herein by reference in full) oh group of the glucopyranose ring C-6 position of this polysaccharide of oxidation, in order to convert it into aldehyde radical (referring to (2006) Chem.Papers 60:243-248 such as Zekovic; It is incorporated herein by reference in full); And with (1 → the 4)-α of this oxidised form-/(1 → 6)-callose is used for reduction amination with the lysine residue of carrier (for example, carrier protein such as BSA) (referring to (1996) J.Org.Chem.61:3849-3862 such as Abdel-Magid; It is incorporated herein by reference in full) reaction, thus produce polysaccharide-carrier conjugates.In some embodiments, the present invention relates to use the isolation technics (Na of for example, ion-exchange, DEAE cellulose and different ionic strength
2HPO
4Damping fluid) (for example separates pure antigen, (1 → 4)-α-/(1 → 6)-callose-BSA conjugate), this pure antigen (for example is used as immune animal, immunize rabbit) solubility immunogene is (referring to (2001) such as Howard " Basic Methods in Antibody Production and Characterization ", CRC Press, 11-18 and 31-50 page or leaf).In some embodiments, the invention still further relates to the affine phase of preparation BSA coating (referring to Matejtschuk (1997) " AffinitySeparations:A Practical Approach ", Oxford University Press) with and from (for example comprising carrier, BSA) antibody and antigen are (for example, (1 → 4)-α-/(1 → 6)-callose) antibody antiserum (for example, rabbit anti-serum) in absorption to special (for example, special to BSA) of carrier thus antibody is conducive to the specific purposes of gained antibody preparation.In some embodiments of the present invention, be used for polysaccharide (for example is conjugated to carrier, protein carrier such as BSA) method can be used for preparing human and animal's vaccine, because this method keeps polysaccharide structures, rather than cause that as typical conjugation methods reducing end modifies (referring to Moreau etc., U.S. Patent No. 6,596,861; It is incorporated herein by reference in full).
As before the antigen, its poor antigen needs modification usually at polysaccharide or oligosaccharides.In some embodiments of the present invention, develop synthetic method, wherein polysaccharide antigen (comprising (1 → 6)-callose) is conjugated to come from or derive from the animal species different from the species that are used for immunity carrier (for example, protein carrier such as BSA) (referring to (2001) such as Howard " Basic Methods in Antibody Production and Characterization ", CRCPress, 11-18 page or leaf and 31-50 page or leaf; Matejtschuk (1997) " Affinity Separations:A Practical Approach ", Oxford University Press).Although the present invention is not subjected to character or the class limitations of used carrier, but BSA is because its commercial availability and have five lysine residues but favourable, and each in described five lysine residues all has the single free amine group group that can put together by number of chemical method and polysaccharide or oligosaccharides (referring to (1996) J.Org.Chem.61:3849-3862 such as Abdel-Magid; Lees etc. (1996) Vaccine 14:190-198; Pawlowski etc. (1999) Vaccine 17:1474-1483; All be incorporated herein by reference in full separately).In some preferred embodiments, the carbohydrates of antigen part and will be water miscible be used to the carrier of puting together.In some embodiments, antigen (for example, (1 → 4)-α-/(1 → 6)-callose polysaccharide) carbohydrates part the reducing end aldehyde radical and be not used in and (for example directly be conjugated to carrier, BSA), structure and the binding capacity of polysaccharide antigen will significantly be changed because make like that.In some embodiments, the present invention is by using acetic anhydride/dimethyl sulfoxide (DMSO) (Ac
2O/DMSO) system is (referring to (2006) Chem.Papers 60:243-248 such as Zekovic; It is incorporated herein by reference in full) in the position oxidation except C3 so that farthest keep the structure of carbohydrates part.
In some embodiments, the invention provides and (for example use yeast cell wall fraction, from the solubility (1 → 4) of brewing yeast cell wall-α-/(1 → 6)-callose) synthetic will be for the preparation of antibody (for example, the method of antigen polyclonal antibody) (for example, (1 → 4)-α-/(1 → 6)-callose-BSA (bovine serum albumin(BSA))) conjugate.In some embodiments, the invention provides immunogenic composition, said composition comprise (1 → 4)-α-/(1 → 6)-callose and/or comprise (1 → 4)-α-/conjugate (for example, protein or glycoconjugate) of (1 → 6)-callose.In some embodiments, antibody compositions of the present invention can be used for detecting yeast cell wall product in the sample of paying close attention to (for example, animal feed sample or derivatives thereof, part or extract).In some embodiments, composition of the present invention be by such as acidic extraction (referring to (2009) J.Instit.Brew.115:1031 such as Kwiatkowsk; It is incorporated herein by reference in full) extract from the material that is rich in glucosan or the product (GEM, ALLTECH, Inc., Nicholasville, KY, USA) that is rich in glucosan.In some embodiments, use dimethyl sulfoxide (DMSO) (DMSO)/acetic anhydride (Ac
2O) potpourri is (referring to (1963) J.Am.Chem.Soc.85:3027 such as Pfizner; It is incorporated herein by reference in full) at the C-6 of glucopyranose ring megadyne temperature and oxidation of polysaccharides (for example, (1 → 4)-α-/(1 → 6)-callose) with C-6 hydroxy methylene (CH
2OH) groups converted becomes aldehyde (CH=O) basic (referring to (20060 Chem.Papers 60:243-248 such as Zekovic; It is incorporated herein by reference in full), and so that the antigen of oxidised form (for example, (1 → 4)-α-/(1 → 6)-callose) can enter with carrier (for example, BSA) reduction amination is (referring to Moreau etc., U.S. Patent No. 6,596,861; Abdel-Magid etc. (1996) J.Org.Chem.61:3849-3862; All be incorporated herein by reference in full separately).
Conjugation methods of the present invention (for example, being included in the polysaccharide activation of C6-OH) provides fully conservative polysaccharide part initial configuration, and thereby is conducive to the antigen preparation.Include but not limited to that periodate oxidation is (referring to (1973) Methods Carb.Chem.5:357-370 such as Hay; It is incorporated herein by reference in full) or polysaccharide or the oligosaccharides activation alternative method of CDAP activation (referring to (1996) Vaccine 14:190-198 such as Lees) produce the polysaccharide of remarkable modification, thereby damage it as the practicality of antigen.
Antibody
Another aspect of the present invention is for the preparation of (for example detecting yeast cell wall fraction, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose) mensuration in the method for immunoglobulin (Ig), said method comprising the steps of: with yeast cell wall fraction (for example, yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/(1 → 6)-callose, (1 → 4)-α-/(1 → 6)-callose-BSA, or its other fragments, variant or conjugate) immune object and from recipient's separating immune globulin.The immunoglobulin (Ig) of preparation is another aspect of the present invention by this method.
The inoculum that is used for the polyclonal antibody preparation prepares usually in the following manner: antigen composition is scattered in such as the thinning agent that can tolerate on the physiology of salt solution or other adjuvants to form waterborne compositions.The inoculum of immunostimulation amount is administered to object, then makes the object of inoculation keep being enough to make antigen composition to cause the time of protection antibody.
Antibody can be such as affinity chromatography (referring to for example Harlow and Lane, Antibodies; A Laboratory Manual (1988) Cold Springs Harbor Laboratory Press) the required degree of technology of knowing is separated.
Antibody comprises the antiserum prepd from multiple conventional animal (for example, goat, primate, rabbit, donkey, pig, horse, cavy, rat or people).Get blood and reclaim serum from animal.
Immunoglobulin (Ig) prepared in accordance with the present invention can comprise complete antibody, antibody fragment or subfragrnent.The complete immunoglobulin (Ig) that antibody can be any classification is IgG, IgM, IgA, IgD or IgE, chimeric antibody or two or more antigens of the present invention are had the hybrid antibody of bispecific for example.They also can be fragment, such as F (ab ') 2, Fab ', Fab, Fv etc., comprise the heterozygosis fragment.
Perhaps, can use methods known in the art change to describe technology for the preparation of single-chain antibody to be fit to the single-chain antibody of preparation specific binding specific antigen.Have relative specific but have the antibody that the Different Individual genotype forms and to produce (referring to for example Burton, Proc.Natl.Acad.Sci.88,1112023,1991) by carry out chain reorganization from random combine immunoglobulin (Ig) library.
Single-chain antibody also can with hybridoma cDNA as template, use the DNA cloning method such as PCR to make up (referring to such as Thirion etc., 1996, Eur.J.Cancer Prev.5,507-11).Single-chain antibody can be monospecific or bispecific, and can be divalence or tetravalence.Tetravalence, bispecific single-chain antibody be structured in for example Coloma﹠amp; Morrison, 1997, Nat.Biotechnol.15 proposes among the 159-63.Divalence, bispecific single-chain antibody be structured in for example Mallender ﹠amp; Voss, 1994, J.Biol.Chem.269 proposes among the 199-206.
Can use artificial or the synthetic nucleotide sequence that makes up the coding single-chain antibody of robotization nucleotide, the Application standard recombinant DNA method is cloned in the expression construct, and in the transfered cell to express described coded sequence, as described below.Perhaps, single-chain antibody can use that (referring to such as Verhaar etc., 1995, Int.J.Cancer 61,497-501 such as the filobactivirus technology; Nicholls etc., 1993, J.Immunol.Meth.165,81-91) directly preparation.
The antibody of specific binding specific antigen also can prepare in the following manner: the group that produces or screen immunoglobulin (Ig) library or high degree of specificity association reaction thing in the body among the induction of lymphocyte group, such as document (referring to such as Orlandi etc., Proc.Natl.Acad.Sci.86,38333837,1989; Winter etc., Nature 349,293 299,1991) disclosed in.
Chimeric antibody can be such as disclosed structure the among the WO 93/03151.Can also prepare derived from immunoglobulin (Ig) and for multivalence and polyspecific in conjunction with albumen, " double antibody " described in WO94/13804.Can be by method antibody purification well known in the art.For example, can come the described antibody of affinity purification by the post that is combined with related antigen by making antibody.Then can use the antibody of damping fluid with high salt concentration elution of bound from the post.
Immunogenic composition of the present invention can be administered to object, then this object serves as the immunoglobulin (Ig) source, and described immunoglobulin (Ig) produces in response to exciting of specific immunogenic composition.The object of so processing will provide blood plasma, will obtain hyperimmune globulin from this blood plasma by the normal plasma fractionation method.
The complete immunoglobulin (Ig) that composition of the present invention includes but not limited to can be any classification (for example, IgG, IgM, IgA, IgD or IgE, chimeric antibody) antibody (for example, monoclonal and/or polyclonal antibody) or two or more antigens of the present invention are had specific hybrid antibody.They also can be fragment, such as F (ab ') 2, Fab ', Fab, Fv etc., comprise the heterozygosis fragment.
The method for preparing monoclonal antibody is well known in the art and can comprises that fusion splenocyte and myeloma cell are (referring to for example Kohler and Milstein 1975 Nature 256; 495; Harlow and Lane, Antibodies; A Laboratory Manual (1988) Cold Springs Harbor Laboratory Press).Perhaps, can obtain monoclonal Fv fragment (referring to such as 1998 Nature Biotechnology 16 such as Vaughan TJ by screening suitable phage display library; 535).Monoclonal antibody can be carried out humanization or part humanization by known method.
In some embodiments of the present invention, antibody compositions can identify yeast cell wall antigen (for example, can identify yeast (1 → 4)-α-D-glucosan, yeast (1 → 6)-callose, yeast (1 → 4)-α-/monoclonal or the polyclonal antibody of (1 → 6)-callose or its fragment, variant or conjugate).In some embodiments, antibody compositions combining yeast cell membrane of the present invention (1 → 4)-α-D-glucosan, but not in conjunction with except the part that contains (1 → 4)-α-D-glucosan that exists in the material outside the polymkeric substance that contains yeast cell wall (1 → 4)-α-D-glucosan (for example, yeast cell wall (1 → 4)-α-D-glucosan, yeast cell wall (1 → 4)-α-/(1 → 6)-callose or its fragment, variant or conjugate).In some embodiments, antibody compositions combining yeast cell membrane of the present invention (1 → 6)-callose, but not in conjunction with except the part that contains (1 → 6)-callose that exists in the polymkeric substance that contains yeast cell wall (1 → 6)-callose (for example, yeast cell wall (1 → 6)-callose, yeast cell wall (1 → 4)-α-/(1 → 6)-callose or its fragment, variant or the conjugate) material in addition.In some embodiments, antibody compositions combining yeast cell membrane of the present invention (1 → 4)-α-/(1 → 6)-callose, but not in conjunction with except exist in yeast cell wall (for example, yeast cell wall (1 → 4)-α-/(1 → 6)-callose or its fragment, variant or the conjugate) material in addition contain (1 → 4)-α-/part of (1 → 6)-callose.
Embodiment
It is in order to show and to further specify some preferred embodiment of the present invention and aspect, limiting the scope of the invention and should not be construed as that following examples are provided.
Extraction (1 → 4)-α from food grade Saccharomyces cerevisiae yeast cell wall beta-glucosan-/(1 → 6)-callose
The preparation of yeast cell wall glucosan
Use deionized water to wash four times to remove any solubility residue by the technical grade (1 → 6) of saccharomyces cerevisiae preparation-callose (ALL-BGY, ALLTECH, Inc., Nicholasville, KY, USA) by enzyme/alkalescence/thermal treatment.After freeze drying, obtain " being rich in the material of glucosan " (" GEM ").
The acid digestion of yeast cell wall glucosan
Fig. 1 illustrates the preparation of various fractions.Described in (2009) J.Instit.Brew.115:151-158 (it is incorporated herein by reference in full) such as Kwiatkowski, carry out the acid digestion of yeast cell wall glucosan.80 ℃ lower will " be rich in the material of glucosan " (" GEM ") (70g) 6h is hydrolyzed with the 100mM HCl (pH 2.2) of 700mL.After this, that potpourri is centrifugal and collect supernatant with 13,500 * g/10 ℃/10min.Sediment is extracted twice and freeze-drying with the 150ml deionized water, obtain the white amorphous products (P1) of 57.9g.
Twice washings is neutralized to pH 7.0 with initial supernatant merging and with 2N NaOH.The precipitation (sediment P1/7) (1.82g after the freeze-drying) that forms by centrifugal collection and be lower than use under 37 ℃ the temperature Buchi vacuum rotary evaporator with supernatant concentration to the 450ml volume.Use 5kDa AMICON 15 ultrafiltration centrifugal devices (Millipore Corporation, Delaware USA) that this solution is further concentrated.By with two parts of isopyknic deionized waters and with identical ultrafiltration apparatus centrifugal come for twice the washing concentrating thing (~150mL), the lower-molecular-weight component that is produced to remove salt and acid hydrolysis.To through concentrate (S1) freeze-drying of washing, obtain the white amorphous products of 7.5g.The reagent of same ratio and condition are carried out the extraction second time to the part of sediment P1 in use and for the first time 0.1N HCl extraction.Thereby these product freeze-drying are obtained P2 and S2.Use to be extracted in 0.1N HCl for the second time and produce precipitation after supernatant neutralized.Reagent and the condition of same ratio are extracted for the third time to the part of sediment P2 in use and for the first time 0.1N HCl extraction, thereby and with product freeze-drying acquisition P3 and S3.Use being extracted in for the third time of 0.1N HCl to produce precipitation after supernatant neutralized.By using
1H NMR spectroscopy is determined to form and polysaccharide structures from the carbohydrates of the solubility of 0.1N HCl extraction and insolubility fraction.Use H
2SO
4-HPLC composition analysis is (referring to (1998) Yeast 14:1297-1306 such as Dallies; It is incorporated herein by reference in full) mannose and glucose content in the analytic sample.With the LECO combustion analysis and by nitrogen content being multiply by the estimator that the factor 6.25 is calculated protein content.
The antigen preparation
(1 → 4)-α-/Ac of (1 → 6)-callose preparation
2The O/DMSO oxidation
580 milligrams of ' solubility ' glucosans are placed on are equipped with in magnetic stirring bar and the 22ml vial with rubber septum sealing.At room temperature and under agitation, use glass syringe in this bottle, to add the anhydrous DMSO of 10ml and 110 μ l acetic anhydride.Under 20 ℃, dextran suspension is fully dissolving in 4h stirs.Continue the 24h that stirs the mixture, after this, with 40ml water diluted reaction mixture.Use 30kDa Amicon
15 ultrafiltration centrifugal devices concentrate the gained settled solution, and with the residue on filtrator washing five times, use the 12ml deionized water at every turn, thereby separate and the purifying oxidation product from solvent and reactant.All are centrifugal all carries out with 4,750 * g/30min/10 ℃.Final residual thing and freeze drying on the de-entrainment filter, thus (1 → the 4)-α of the oxidation of acquisition 502mg white powder form-/(1 → 6)-callose.This product is partially soluble in the water and is dissolved among the DMSO fully.
Ultimate analysis
The measured value of the glucosan of oxidation: C-40.05%; H-6.61%.C
6H
8O
5X H
2The calculated value of O: C-40.48%; H-5.66%
(1 → the 4)-α of oxidation-/reduction amination of (1 → 6)-callose and BSA
With (1 → the 4)-α of 412mg oxidation-/(1 → 6)-callose sample dissolution in the 20ml deionized water, then under magnetic agitation, mix with the solution of 256mg BSA in the 2ml deionized water.Then use this potpourri of 60mg sodium cyanoborohydride solids treatment.To react bottle and seal with rubber septum, and potpourri will be stirred 24h under 20 ℃.After this, add the 100mg sodium borohydride and potpourri is stirred 22h again.Then pass through 30kDaAmicon
15 ultrafiltration centrifugal devices filter this settled solution with 4,750 * g/30min/10 ℃.Debris is four times on filtrator, uses 12ml water at every turn, and with final concentrate freeze-drying, thereby obtain the 573mg white powder.
Ultimate analysis
C?45.01%、H?6.40%、N?2.11%。
(1 → 4)-α-/the DEAE cellulose ion exchange chromatography of (1 → 6)-β D-glucosan-BSA conjugate separates
With the rough conjugate of 400mg in the 5mM of 5ml Na
2HPO
4In solution be introduced into 2 * 55cm glass column top, this chromatographic column is contained in 5mM Na
2HPO
4In the 50gDEAE cellulose.Use the Na of variable concentrations
2HPO
4The following material of wash-out: 40.1mg (1 → 4)-α-/(1 → 6)-callose (220ml, 5mM); 132.3mg pure (1 → 4)-α-/(1 → 6)-callose-BSA conjugate (280ml, 55mM); And 96.7mgBSA (80ml, 100mM).Use 30kDa AMICON15 ultrafiltration centrifugal device with pure (1 → 4)-α-/(1 → 6)-callose-BSA conjugate solution is concentrated into the 2ml volume, use deionized water washing and freeze-drying, thereby obtain 132.3mg (24.4% overall yield) white powder sample product.Gel electrophoresis produces by the broadband of using Coomassie blue and PAS dyeing to disclose, and its central authorities are positioned at~the 170kDa place.In electrophoretogram, do not detect free BSA or any other impurity.
Ultimate analysis
C?40.11%、H?6.23%、N?3.06%、(20.44w%BSA)。The beta glucan that calculates: the ratio of BSA is 4: 1.
Polyclonal antibody preparation and purifying
Antigen preparation and rabbit immunity
The antigen freeze-drying that the BSA-that 10mg is prepared as described in example 2 above puts together is kept under 4 ℃, and is used for three rabbits of immunity (each immune 200 μ g antigens).Listed in immunization protocol such as the table 1.
Table 1. be used for rabbit produce anti--(1 → 4)-α-/immunization protocol of (1 → 6)-callose-BSA polyclonal antibody.
| Action | |
0 | Setting, the blood of looking ahead, initial immunity | |
21 | Advance | |
35 | Advance | |
44-45 | Get blood | |
49 | Advance | |
58-59 | Get blood | |
63 | Get blood |
The affine phase purifying of polyclonal antibody
1 gram epoxy activated agarose (Sigma E 6632) is suspended in 2.68g BSA (SIGMAA2153) in 27ml 10mM Na
2HPO
4In solution in, and this potpourri stirred in ice-water bath 4 hours under 4 ℃.After this, this potpourri is centrifugal with 2500 * g/5min/10 ℃, and with sediment washing also centrifugal four times again, use 30ml 100mMNa at every turn
2HPO
4/ 0.05w%NaN
3
The last centrifugal sediment of the affine phase (above-mentioned) that will apply from BSA is suspended in 750 μ l serum (collecting from the rabbit of using ' solubility ' glucosan-BSA conjugate immunity) in 20ml 10mM Na
2HPO
4/ 0.05w%NaN
3In solution in, and the 2h that at room temperature rolls, then centrifugal with 1500 * g/5min/10 ℃.Collect supernatant and use the 20ml same buffer to wash three times sediment again, this causes regathering three portions of supernatants.Supernatant is checked that it to the specificity of BSA and ' solubility ' glucosan, goes out as shown in Figure 2.First and second supernatants that will comprise the antibody of significant quantity concentrate in together, and by use 10kDaAMICON Ultra-15 centrifugal filter device with 5000 * g/5min/10 ℃ of centrifugal concentrating to the 2.5ml volume.Use 10mM Na
2HPO
4/ 0.05w%NaN
3Washing concentrating thing and use same buffer that it is diluted to 6ml volume (6g) on filtrator.1: 800 dilution that will be somebody's turn to do ' antibody of affinity purification ' solution is used for the MYCOSORB of animal feed is carried out ELISA mensuration.The calibration curve that obtains is shown among Fig. 3.
By ELISA detect (1 → the 4)-α of yeast cell wall-/(1 → 6)-callose
Materials and methods
Reagent
Except as otherwise noted, otherwise applicable reagent of generally acknowledging AG only, and deionized water remove fossil water or water purity quite (at 25 ℃ of lower 18,2M Ω/cm).
Being prepared as follows of reagent and reagent solution:
Hydrochloric acid, 12.1N; HCl
Watery hydrochloric acid, 1N; HCl: 41.3ml HCl 121N is slowly added in the 400ml deionized water and use stirring rod to mix until cooling at agitator disk.Transfer to this solution in the 500ml volumetric flask and use the deionized water constant volume, then at room temperature preserve.
Dimethyl sulfoxide (DMSO): used DMSO is high-purity, is applicable to spectrophotometric method, liquid phase chromatography and vapor-phase chromatography.
Extract reagent: in order to prepare extraction reagent, with 900ml DMSO and 98.75ml deionized water and 1.25ml HCl 12,1N mixes.At room temperature on agitator disk, use stirring rod to mix this solution with the medium speed, then 20 ℃ of lower or above preservations.
Sodium chloride (" NaCl ")
Potassium chloride (" KCl ")
Sodium hydrogen phosphate (" Na
2HPO
4")
Potassium dihydrogen phosphate (" KH
2PO
4")
Phosphate buffer (" PBS ") 10X: in order to prepare 10X PBS, 80.0g sodium chloride [NaCl], 2.0g potassium chloride [KCl], 14.2g sodium hydrogen phosphate [Na2HPO4] and 2.4g potassium dihydrogen phosphate [KH2PO4] are mixed with about 800ml deionized water.Use stirring rod to stir this solution until solid dissolves fully at agitator disk.Transfer to this solution in the 1000ml volumetric flask and use the deionized water constant volume, then at room temperature or 2-8 ℃ of lower the preservation.It is 6 months as the maximum storage time of undiluted solution under 2-8 ℃.Before using, this solution is risen to room temperature.
Rare PBS, 1X: in order to prepare 1X PBS, with the PBS of 1 volume, 10X dilutes with the deionized water of 9 volumes.At room temperature on agitator disk, use stirring rod to mix this dilution with the medium speed.Maximum storage time is one day.
Polysorbate20
Contain the 0.01M phosphate buffer of 0.05% polysorbate20, pH 7.4: in order to prepare, with the contents melting of a pouch in the 1000ml deionized water.Stir this solution until then fully dissolving at room temperature or under 2-8 ℃ preserves at agitator disk.It is 6 months as the maximum storage time of undiluted solution under 2-8 ℃.Before using, this solution is risen to room temperature.
Skimmed milk power
The skimmed milk power in PBS of 3% (w/v), 1X sealer: in order to prepare the 1X sealer, before use dried milk is dissolved among the 1X PBS fully.Each plate needs the 10ml volume to seal.Maximum storage time is one day.
Rabbit polyclonal antibody; One-level antibody (antibody-solutions #1): the antibody of the affinity purification of preparation as described herein.For subsequent use-80 ℃ of lower maintenances.
The rabbit polyclonal antibody solution of dilution: by 1 μ l antibody-solutions # 1 is joined X
iμ lPBS is among the 1X and be diluted to 1 in PBS: X
iEach microtiter plate needs the solution of 10ml volume.Antibody-solutions with dilution mixes before use, and discards the antibody of unnecessary dilution.Maximum storage time is one day.
The affinity purification goat anti-rabbit igg (H+L) of peroxidase conjugated; The HRP secondary antibody, Ref.#111-035-045 (Jackson ImmunoResearch, PA, USA-antibody-solutions #2): use 1.5ml deionized water aquation and centrifugal until obtain the fully solution of clarification.Save backup under-80 ℃ with 10 μ l aliquots.It was 6 weeks as the maximum storage time of undiluted solution under 2-8 ℃.
The goat anti-rabbit antibody of dilution: by 1 μ l antibody-solutions # 2 is joined Y
iμ l PBS is among the 1X and be diluted to 1 in PBS: Y
iAntibody-solutions with dilution mixes before use, and discards the antibody of unnecessary dilution.Maximum storage time is one day.
SureBlue Reserve TMB Microwell peroxidase substrate: only redistribute in amber Nalgene HDPE and LDPE bottle volume required.Before using, substrate is risen to room temperature.Capping is kept closing lucifuge.Discard unnecessary substrate, and this reagent is preserved under 2-8 ℃.When 8 ℃ of lower preservations, maximum storage time is 24 months from making.
MYCOSORB lays in sample; Criticize reference number 285965 (ALLTECH, Inc., KY, USA): use uniform MYCOSORB sample.
The dilution of MYCOSORB in feedstuff: in the 250ml centrifugal bottle with the MYCOSORB product (0.01 of 20g feed material and incremental change; 0.02; 0.08; 0.10; 0.12g) mix (triplicate) to generate typical curve.With bottle on the rail mounted oscillator with 400rpm shake 1h.The precision of weighing feed material equals ± 0.025g, and for the MYCOSORB product, precision is ± 0.005g.
The large batch of MYCOSORB that in the feed material, dilutes: in the 1000ml container, use 1.2g product and 300g feed material to prepare the sample of a large amount of MYCOSORB products that in feed, dilutes.With bottle on the rail mounted oscillator with 400rpm shake 1h.The ultimate density of MYCOSORB product in the feed material is 4.0kg/T.20.0g in the large batch of feed-product mixture of the 300.0g that homogenizes is transferred in the 250ml centrifugal bottle.Repeat again this transfer 9 times to obtain 10 replicate determination samples.Between 3 aliquots of every preparation off and on this potpourri of shake to avoid product to be deposited to bottle bottom.The precision of weighing feed material equals ± 0.025g, and the MYCOSORB Product Precision is ± 0.005g.
The dilution of the MYCOSORB of unknown quantity in feedstuff: by with the MYCOSORB product of unknown quantity and 20.0g (± 0, prepare unknown sample in each of the 250ml centrifugal bottle of feed material transfer to five 025g).With bottle on the rail mounted oscillator with 400rpm shake 1h.Finish simultaneously the sample preparation of the typical curve of sample.
The sample prescription
Three feed material (referring to table 4, table 5 and table 6) is used for verifying described mensuration.Select the feed material prescription according to the already present composition in this area.Sample size is 15kg feed material altogether, this feed material before being delivered to the laboratory through careful homogeneity.During whole research, with Sample storage under 2-8 ℃.
The checking of sample homogeneity
By being that 4.0kg/T prepares the large batch of MYCOSORB product that is diluted in the feed with the intermediate concentration of product in feed, verify the homogeneity of the dilution of MYCOSORB product in the feed material.Sample is divided into 10 subsamples, and further extracts according to extraction procedure, then measure the coefficient of variation of determining the product detection by in 10 samples each is carried out four ELISA.
Sample preparation
The preparation of standard model is as described herein to be carried out and is shown in Table 2, and wherein tests with the MYCOSORB product.In this case, with reference to initial deposit product as described herein.Unknown sample is according to as mentioned above preparation.Before carrying out extraction procedure, do not need to grind Feed Sample, (if the feed material provides with granulated form, not needing to grind) yet.It is found that, grind the final reliability that the feed material can affect mensuration.
Table 2. is used for the dilution step of the MYCOSORB product of typical curve.
aThe dilution gfactor that represents of kilogram number with MYCOSORB product in the feed material per ton
bFeed scope=± 0,025g,
cMYCOSORB product scope=± 0,005g
dWherein C is MYCOSORB amount unknown in the feedstuff
Extraction procedure
With whole group the bottle on the rail mounted oscillator with 400rpm shake 1h.Each three bottles of taking-up also use the mouthvolume divider to the extraction reagent of each bottle interpolation 80ml volume.With the bottle capping.Manually the shake all samples is to guarantee and to extract reagent and mix fully.Bottle is placed 1h in the water-bath that keeps 80 ℃ of constant temperature, guarantee that feedstuff soln is immersed in the water fully.After hatching, bottle is taken out from water-bath and use high moment of torsion laboratory stirrer with the content of stirring rod (NALGENE brand) hybrid bottle.The complete homogeneity of potpourri.Each MYCOSORB is comprised level all use clean stirring rod with each unknown sample.Bottle is placed 1h again in the water-bath that keeps 80 ℃ of constant temperature.After hatching, bottle taken out from water-bath and use the mouthvolume divider to add the 80ml deionized water to each bottle, then with the bottle capping.Manually the shake bottle is until mix fully; Use in case of necessity the NALGENE brand stirring rod of following high moment of torsion laboratory stirrer.With bottle with the centrifugal 10min of 8,000g.Use glass pipette, about 10ml supernatant is transferred in the aseptic centrifuge tube of 15ml.With pipe with the centrifugal 10min of 4,000g and transfer to by decant in the aseptic centrifuge tube of 15ml of new suitable mark.Pipe is spent the night until be used for ELISA mensuration-20 ℃ of lower preservations.
The ELISA program
SureBlue Reserve TMB Microwell peroxidase substrate is used for by reacting with the HRP secondary antibody of dilution, further trigger chrominance response with the one-level antibody response of dilution, this one-level antibody self reacts with institute's substrate specificity of paying close attention to that MYCOSORB product from dilution extracts, and the MYCOSORB product of described dilution is fixed on the microtiter plate.Use HCl after the 20min, 1N finally stops this chrominance response, and reads reading to carry out absorbance with the 450nm wavelength on the plate instrument.Therefore, the blank of only being made by the feed material is measured, changed to explain the possible colorimetric from feed substrate, described feed substrate produces background signal at spectrophotometer.In order to calculate, from the absorbance that each sample is obtained, deduct blank value.
The before this sample of extraction that preservation is spent the night thaws and rises to room temperature.Before the hole that is used for ELISA coating microtiter plate, that the sample vortex is even to guarantee sample.
Repeat for each sample, 100 μ l supernatants are transferred in each of 3 holes on the 96 hole microtiter plates, as shown in table 3.Can carry out sample randomization onboard in the laboratory that is equipped with sequencing automatic fine titration hole divider distributes.Typical curve sample and sample are repeated all to be distributed on the plate of a uniqueness (that is, all 0kg/T samples repeat the fixing onboard whole row of E1 to F10/row).Unknown MYCOSORB replicate determination sample is distributed in (that is, the fixing onboard whole row of A11 to C12/row) on the same plate.With microtiter plate with microplate binder film sealing and under 37 ℃, hatch 1h.After hatching, remove in each hole of microtiter plate solution and with 250 μ l PBS, 1X replaces to carry out single wash.Repeat again this operation 2 times altogether.1h is also at room temperature hatched with the dilute solution sealing of skimmed milk power in PBS of 100 μ l in each hole of microtiter plate.After hatching, remove in each hole solution and with 250 μ l PBS, 1X replaces to carry out single wash, then comprises the PBS washing 2 times of 0.05% polysorbate20 with 250 μ l.
The one-level antibody of the dilution of 100 μ l volumes is added in each hole.Microtiter plate is at room temperature hatched 1h.After hatching, remove in each hole of microtiter plate solution and with the PBS that comprises 0.05% polysorbate20 of 250 μ l, 1X replaces to carry out 3 washings.
The secondary antibody of the dilution of 100 μ l volumes is added in each hole.Microtiter plate is at room temperature hatched 1h.After hatching, remove in each hole of microtiter plate solution and with the PBS that comprises 0.05% polysorbate20 of 250 μ l, 1X replaces to carry out 3 washings.
The tmb substrate that is preheated to room temperature of 100 μ l volumes added in each hole and with microtiter plate at room temperature hatch 20min.After hatching just in time 20min with tmb substrate, with the HCl of 100 μ l volumes, 1N adds to immediately in each hole and develops to stop colorimetric.On the microtiter plate reading apparatus, read each microtiter plate with 450nm.
Sample sets on table 3. microtiter plate is distributed.
*Wherein C be in the feedstuff unknown MYCOSORB product comprise level
** the sample sets sign is referring to table 2
Get rid of data from replicate determination
Need analysis of statistical data guaranteeing all replicate determinations as similarly, thus get rid of do not pass through Dixon ' s Q check and therefore according to as give a definition and be identified as those of exceptional value: Q
n=| x
a-x
b|/R, wherein R is the scope of all data points; x
aBe doubtful exceptional value; x
bFor near x
aData point.If Q
Calculate>Q
Table, then refuse problematic point in 95% fiducial interval.
Standard curve making
The Application standard curve carries out quantitatively.Use interior at least five levels (comprising zero) of working range of product to come every kind of feed substrate is made up typical curve, described in council's instruction (CouncilDirective) 96/23.Calculate each sample sets at OD
450Under the mean value of three replicate determinations of hole absorbance.Calculate blank Feed Sample at OD
450Under the mean value of ten replicate determinations of hole absorbance.Then the difference DELTA OD to obtain
450(OD
450Sample sets-OD
450Blank feed) for ordinate and take different MYCOSORB product design scopes 0.5,1.0,4.0,5.0,6.0kg/T as horizontal ordinate production standard curve or calibration curve.
After with average blank value institute's measured value being proofreaied and correct, use best-fit line Δ OD according to linear regression
450What=Ax (MYCOSORB) calculating was drawn comprises level to OD
450Regression coefficient and the equation of the figure line that absorbs.The acceptable scope of calibration curve and the linearity are by being higher than 0.95 related coefficient (r
2) value verifies.Then come to determine by separating this counterparty's formula the level that comprises of MYCOSORB product in the unknown sample with counterparty's formula of described curve.
Interpolation
Be higher than r if find the related coefficient of typical curve
2>0.95, then then use counterparty's formula F (x) of calibrated curve=Ax, (background correction signal and intercepting zero) determines the level that comprises of MYCOSORB product in the unknown sample.Calculate the unknown and comprise the MYCOSORB product of level (C) at OD
450Under the mean value of ten replicate determinations.The mean value that obtains is deducted the blank Feed Sample of before this calculating at OD
450Under the mean value of ten replicate determinations of hole absorbance.Then use OD
450Mean value is separated calibrated curve F
-1(y
C) equation, y wherein
C=Ax
C:
x
C=y
C/ A, wherein y
CThe average OD of the unknown sample that equals to obtain (C)
450Deduct blank OD
450, x
CFor the MYCOSORB of correspondence comprises level, and A is the slope of typical curve, and unit is kg/T OD
450
Detectability and quantitative limit
Measure detectability (L according to the IUPAC nomenclature
D=3 σ
Blank) and quantitative limit (L
Q=10 σ
Blank) and be given as Δ OD
450
Determine detectability (L by the matrix blank analysis
D) and quantitative limit (L
Q), and Application standard curve F (x)=Ax is calculated to be free average background OD
450The concentration of the linear regression that value is proofreaied and correct, described typical curve is as follows according to following parsing:
L
D=3 σ
Blank/ A and L
Q=3 σ
Blank/ A, wherein L
DBe detectable minimal product concentration or detectability; L
QBe minimal product concentration or quantitative limit that can be quantitative.
Homogeneity
The homogeneity coefficient of variation (RSD
H=CV
H) be defined as the average coefficient of variation of measuring in 10 independent parallel that obtained from same sample by constructed librarian use identical device and method on the same day.
Precision: repeatability
Test crowd interior repeated precision (RSD
In=CV
In) be defined as the average coefficient of variation in the repetition that is obtained from the same sample of same BT(batch testing) by constructed librarian use identical device and method on the same day.
Repeated precision (RSD between test is criticized
Between=CV
Between) be in the average coefficient of variation that is not obtained on the same day independent results by constructed librarian use identical device and method from the same sample of different BT(batch testing)s.
Precision: overall precision
Conforming dispersion degree (or degree of approach) between the METHOD FOR CONTINUOUS DETERMINATION result of precision evaluation same amount.The dispersiveness of one group of measurement result represents with standard deviation usually.Therefore precision is by at the single standard deviation that comprises the single independent experiment of level that is obtained from same sample by constructed librarian use identical device and method on the same day; The standard deviation that each independent test of relatively being undertaken by constructed librarian use identical device and method is criticized, calculate according to following formula:
σ wherein
AlwaysBe the standard deviation of whole experiments of organizing, σ
InBe the standard deviation of single independent experiment, σ
BetweenBe the standard deviation between a plurality of experiments, and n is the replicate determination number.
F check (p value≤0.05) between the variance of relatively passing through the use class mean of standard deviation and the average of interclass variance is realized by variance analysis (single factor ANOVA).
Accuracy
Accuracy is to be found in the test result of measured product and to accept the conforming degree of approach between the reference value.Therefore the recovery that is shown percentile by meter is estimated accuracy.In this respect, the recovery represents to exist or admix in the analyte ratio of the amount of analyte, and described analyte also can be used for measuring through extracting.Deviation is test result and accepts difference between the reference value (the mark-on concentration of analyte).Calculate according to following formula:
X wherein
cBe the concentration of measuring in the mark-on sample; X
bBe the concentration of measuring in the mark-on sample (blank) not; X
THBe theoretical concentration.
The feed material that is used for validation test
At ALLTECH, Inc., KY, the Animal nutrition genomics of USA is tested from dairy feed preparation, chicken feed formulations and pig feed preparation that the different MYCOSORB Product mixes that comprise level form the feed material with applied animal threpsology center (Center for Animal Nutrigenomics and Applied AnimalNutrition).The complete description of feed formulations is listed in hereinafter.
The dairy feed material
This feed material is by Coralis Vern (Vern sur Seiche, France, Ref.#111605) preparation, and its prescription name is called " Spirit Lait 2L5 " (table 4).Sample size is 15kg feed material altogether, this feed material before being delivered to the laboratory through careful homogeneity.During whole research, with Sample storage under 2-8 ℃.This dairy feed material provides with granulated form.Before carrying out extraction procedure, do not need to grind Feed Sample.
Table 4. is used for verifying the dairy feed prescription of described method.
*Be used for limiting protein content and the animal protein demand of feed, the two is true protein (" the PDI ") expression can truly digest in the small intestine all.The PDI content of diet is (i) PDIA part, does not namely degrade in cud but the dietary protein that can truly digest in small intestine; (ii) PDIM part, the summation of the microorganism true protein that namely in small intestine, can truly digest.To be that microprotein is synthetic by degradable nitrogen (PDIMN) and its available energy (PDIME) that provides for rumen microorganism all contribute for every kind of feed.Consider following two formula: (1) PDIN=PDIA+PDIMN and (2) PDIE=PDIA+PDIME, the value of every kind of feed directly provides by the summation of PDIA and PDIM.
Chicken feed material
This feed material is at University of Kentucky and ALLTECH, Inc., KY, the joint study group Coldstream University of Kentucky place preparation (table 5) between the USA.Exist and the composition that may extend to the prescription that is common in European Union, North America, Latin America etc. is prepared according to this area.Sample size is 15kg feed material altogether, this feed material before being delivered to the laboratory through careful homogeneity.During whole research, with Sample storage under 2-8 ℃.
Table 5. is used for verifying the chicken feed additive of described method.
aThe vitamin that every kg diet provides: 2200IU vitamin A; The 720ICU cholecalciferol; The 27IU vitamin E; 0,91mg prokeyvit (2-MNQ); The 2mg thiamines; 8mg lactochrome; 55mg nicotinic acid; The 18mg calcium pantothenate; 5mg vitamin B6 (pyridoxol); 0,221mg biotin; 1mg folic acid; The 478mg choline; 28 μ g cobalamins (cyanocobalamin).
The pig feed material
This feed material is at University of Kentucky and ALLTECH, Inc., KY, the joint study group Coldstream University of Kentucky place preparation (table 6) between the USA.Exist and the composition that may extend to the prescription that is common in European Union, North America, Latin America etc. is prepared according to this area.Sample size is 15kg feed material altogether, this feed material before being delivered to the laboratory through careful homogeneity.During whole research, with Sample storage under 2-8 ℃.
Table 6. is used for verifying the formula for pig forage of described method.
Use the dairy feed material identification
At ALLTECH, Inc., KY, the Animal nutrition genomics of USA and applied animal threpsology center (Center for Animal Nutrigenomics and Applied Animal Nutrition) tests the European type solid dairy feed prescription of the MYCOSORB product that is mixed with five variable concentrations.
To respectively with 0.0; 0.5; 1.0; 4.0; 5.0; 6.0kg/T the dairy feed material of MYCOSORB Product mix and the sample that is distributed in the identical dairy feed material of on the identical microtiter plate and MYCOSORB Product mix unknown level analyze.
Applicability
Carry out this checking and be in order to determine that ELISA that exploitation is used for specificity analyses MYCOSORB product and substitute measures the characteristic that is intended to follow the trail of the traceability terminal point program of product described in the complicated feedstuff as a kind of.
Use six MYCOSORB Product Levels to verify, these six levels comprise horizontal working range (0.0 corresponding to being mixed in the Feed Sample; 0.5; 1.0; 4.0; 5.0; 6.0kg/T).
The rabbit polyclonal antibody solution of dilution: adjust the one-level antibody dilution according to background level.Therefore by 1 μ l antibody-solutions # 1 is joined 1.2ml PBS, among the 1X and antibody is diluted to 1: 2 in PBS, 500.Each microtiter plate needs the solution of 10ml volume.
The goat anti-rabbit antibody of dilution: adjust the secondary antibody dilutability according to background level.Therefore by 1 μ l antibody-solutions # 2 is joined 20.0ml PBS, among the 1X and antibody is diluted to 1: 20 in PBS, 000.
Homogeneity
In planning of experiments, intermediate value is comprised the homogeneity checking of MYCOSORB product (4.0kg/T) the acquisition sample of level.To repeat 5 times being determined on 10 independent samples of this specified level, each sample uses 4 repetitions.
According to the calculated value that sees in detail in the table 7, CV
HBe 4.53%.
The table 7. pair single concentration that is mixed in the European type cow diet is the homogeneity evaluation of the MYCOSORB product of 4.0kg/T, and it carries out 5 BT(batch testing)s by the ELISA program to the independent sample preparation of 10 replicate analysis 4 times and estimates.
Proofread and correct
Feed to the MYCOSORB product that is mixed with as described herein and known standard model concentration in 0.0 to 6.0kg/T scope is measured correction.Linearity curve match y=Ax is used for limiting concentration and response (OD
450) between relation.Mean value typical curve from 5 BT(batch testing)s is shown among Fig. 4.
The linearity
By using best-fit line (intercept is at zero place) Δ OD after blank according to deduction
450What=Ax (MYCOSORB) drew comprises level to OD
450The equation of the figure line that absorbs calculates the linearity that regression coefficient is come the evaluation criterion curve, is higher than r owing to find facies relationship numerical value
2>0.95 and the linearity of criterion of proof curve, table 8.
The linearity of table 8. typical curve.
*Square error is defined as in linear regression model (LRM):
Wherein
y
iY value for measuring;
Expectation x for the MYCOSORB product
iThe theoretical value of concentration.
Repeatability
Repeatability is measuring by the inside variation of assessment repeatability standard deviation.By the reproducibility in the repetition that is obtained on the same day same BT(batch testing) by constructed librarian use identical device and method from the same sample of same BT(batch testing), to represent the detection variation CV in the same BT(batch testing)
In(table 9).By not obtaining reproducibility between the different BT(batch testing)s by constructed librarian use identical device and method from the same sample of different BT(batch testing)s on the same day, to represent the detection variation CV between the different BT(batch testing)s
Between(table 10).
The result is presented on the same day and all has less variability at the typical curve that does not obtain on the same day, and when be applied to 0.0 and 6.0kg/T between the typical curve working range time average withinday precision be 5.70% and day to day precision be 7.86%.Overall precision is 8.28% (table 11).
Interior repeated precision is criticized in the test that table 9. typical curve makes up.
Repeated precision between the test that table 10. typical curve makes up is criticized.
The overall precision that table 11. typical curve makes up.
L
DAnd L
Q(sensitivity)
L
DAnd L
QValue record is in table 12.Find L
QIt is 2kg/T that the recommendation minimum that value is lower than the MYCOSORB product comprises rate, thereby makes it possible to this product in the feed material is carried out quantitatively.
Detectability L
D=0.501 ± 0.103kg/T
Quantitative limit L
Q=1.800 ± 0.389kg/T
Table 12.L
DAnd L
QMeasure.
Accuracy
By 5 independent experiments (each experiment comprises 10 independent sample and each sample repeated test 4 times) to being mixed into the MYCOSORB product accuracy of measurement of the 4.0-kg/T concentration in the feed material.Formula according to above statement uses the measured value that is used for homogeneity calculating that obtains to calculate the ultimate density (table 13) of each sample.Then calculate average precision by the bat that all tests are obtained, and compare with the mark-on concentration amount 4.0-kg/T that is mixed into the MYCOSORB product in the feed material.Carry out this calculating according to formula given above.
The result shows that it is that the mark-on concentration of MYCOSORB product is over-evaluated 21% (table 14) that recovery assessment causes real content to the feed material.
Accuracy and precision that table 13. is measured the MYCOSORB product that is mixed into the 4.0-kg/T concentration in the feed material by 5 independent experiments (each experiment comprises 10 independent sample and each sample repeated test 4 times).
Table 14. is by 5 independent experiments overall recovery of on average the MYCOSORB product that is mixed into the 4.0-kg/T concentration in the feed material being measured of (each experiment comprises 10 independent sample and each sample repeated test 4 times).
Use chicken feed material identification
At ALLTECH, Inc., KY, the Animal nutrition genomics of USA and applied animal threpsology center (Center for Animal Nutrigenomics and Applied Animal Nutrition) tests the solid chicken feed additive of the MYCOSORB product that is mixed with five variable concentrations.
To respectively with 0.0; 0.5; 1.0; 4.0; 5.0; 6.0kg/T the chicken feed material of MYCOSORB Product mix and the sample that is distributed in the identical chicken feed material of on the identical microtiter plate and MYCOSORB Product mix unknown level analyze.
Applicability
Carry out this checking and be in order to determine that ELISA that exploitation is used for analyzing MYCOSORB product and substitute measures the characteristic that is intended to follow the trail of the traceability terminal point program of the aforementioned product of complicated feedstuff as a kind of.
Use six MYCOSORB products (Ref.#285965) level to verify, these six levels comprise horizontal working range (0.0 corresponding to being mixed in the Feed Sample; 0.5; 1.0; 4.0; 5.0; 6.0kg/T).
The rabbit polyclonal antibody solution of dilution: adjust the one-level antibody dilution according to background level.Therefore by 1 μ l antibody-solutions #1 (4.15) is joined 7.5ml PBS, among the 1X and antibody is diluted to 1: 7 in PBS, 500.Each microtiter plate needs the solution of 10ml volume.
The goat anti-rabbit antibody of dilution: adjust the secondary antibody dilutability according to background level.Therefore by 1 μ l antibody-solutions # 2 is joined 30.0ml PBS, among the 1X and antibody is diluted to 1: 30 in PBS, 000.
Homogeneity
In planning of experiments, intermediate value is comprised the homogeneity checking of MYCOSORB product (4.0kg/T) the acquisition sample of level.To repeat 5 times being determined on 10 independent samples of this specified level, each sample uses 4 replicate determinations (table 15).
The table 15. pair single concentration that is mixed in the chicken feed material is the homogeneity evaluation of the MYCOSORB product of 4.0kg/T, and it carries out 5 BT(batch testing)s by the ELISA program to the independent sample preparation of 10 replicate analysis 4 times and estimates.
Proofread and correct
The feed that is mixed with known standard model concentration and the MYCOSORB product in 0.0 to 6.0kg/T scope is measured correction, use linearity curve match y=Ax limiting concentration and response (OD
450) between relation, be shown among Fig. 5 from the average curve of 5 BT(batch testing)s.
The linearity
By using best-fit line (intercept is at zero place) Δ OD after blank according to deduction
450What=Ax (MYCOSORB) drew comprises level to OD
450The equation of the figure line that absorbs calculates the linearity that regression coefficient is come the evaluation criterion curve, is higher than r owing to find facies relationship numerical value
2>0.95 and the linearity of criterion of proof curve.Regression coefficient to each standard testing curve and average standard testing curve calculation is recorded in the table 16.
The linearity of table 16. chicken feed material Plays curve.
*Square error is defined as in linear regression model (LRM):
Wherein
Yi is the y value of measuring;
Theoretical value for the expectation xi concentration of MYCOSORB product.
Repeatability
Repeatability is measuring by the inside variation of assessment repeatability standard deviation.By the reproducibility in the repetition that is obtained on the same day same BT(batch testing) by constructed librarian use identical device and method from the same sample of same BT(batch testing), to represent the detection variation CV in the same BT(batch testing)
In(table 17).By not obtaining reproducibility between the different BT(batch testing)s by constructed librarian use identical device and method from the same sample of different BT(batch testing)s on the same day, to represent the detection variation CV between the different BT(batch testing)s
Between(table 18).
The result is presented on the same day and all has less variability at the typical curve that does not obtain on the same day, and average withinday precision is 6.00%.Yet, when be applied to 0.0 and 6.0kg/T between the typical curve working range time, the difference of sample room is more obvious, day to day precision be 21.52% and overall precision be 21.75% (table 19).
Interior repeated precision is criticized in the test that table 17. typical curve makes up.
Repeated precision between the test that table 18. typical curve makes up is criticized.
The overall precision that table 19. typical curve makes up.
L
DAnd L
Q(sensitivity)
L
DAnd L
QValue record is in table 20.Find L
QThe recommendation that value is lower than the MYCOSORB product comprises rate, thereby makes it possible to this product in the feed material is carried out quantitatively.
Detectability L
D=0.547 ± 0.237kg/T.
Quantitative limit L
Q=1.864 ± 0.806kg/T.
LD in the table 20. chicken feed material and LQ measure.
Accuracy
By 5 independent experiments (each experiment comprises 10 independent sample and each sample repeated test 4 times) to being mixed into the MYCOSORB product accuracy of measurement of the 4.0-kg/T concentration in the feed material.The measured value that is used for homogeneity calculating that use as described herein obtains is calculated the ultimate density (table 21) of each sample.Then compare by the bat calculating average precision to all tests batch acquisition, and with the mark-on concentration amount 4.0-kg/T that is mixed into the MYCOSORB product in the feed material.The formula that provides according to this paper carries out this calculating.
The result shows that it is that the mark-on concentration of MYCOSORB product is over-evaluated 18% (table 22) that the recovery causes real content to the feed material.
Accuracy and precision that table 21. is measured the MYCOSORB product that is mixed into the 4.0kg/T concentration in the feed material by 5 independent experiments (each experiment comprises 10 independent sample and each sample repeated test 4 times).
Table 22. is by 5 independent experiments overall recovery of on average the MYCOSORB product that is mixed into the 4.0kg/T concentration in the feed material being measured of (each experiment comprises 10 independent sample and each sample repeated test 4 times).
Use the pig feed material identification
At ALLTECH, Inc., KY, the Animal nutrition genomics of USA and applied animal threpsology center (Center for Animal Nutrigenomics and Applied Animal pig Nutrition) tests the solid formula for pig forage of the MYCOSORB product that is mixed with five variable concentrations.
To respectively with 0.0; 0.5; 1.0; 4.0; 5.0; 6.0kg/T the pig feed material of MYCOSORB Product mix and the sample that is distributed in the identical pig feed material of on the identical microtiter plate and MYCOSORB Product mix unknown level analyze.
Applicability
Carry out this checking and be in order to determine that ELISA that exploitation is used for analyzing MYCOSORB product and substitute measures the characteristic that is intended to follow the trail of the traceability terminal point program of product described in the complicated feedstuff as a kind of.
Use six MYCOSORB Product Levels to verify, these six levels comprise horizontal working range (0.0 corresponding to being mixed in the Feed Sample; 0.5; 1.0; 4.0; 5.0; 6.0kg/T).
The rabbit polyclonal antibody solution of dilution: adjust the one-level antibody dilution according to background level.Therefore by 1 μ l antibody-solutions # 1 is joined 3.5ml PBS, among the 1X and antibody is diluted to 1: 3 in PBS, 500.Each microtiter plate needs the solution of 10ml volume.
The goat anti-rabbit antibody of dilution: adjust the secondary antibody dilutability according to background level.Therefore by 1 μ l antibody-solutions # 2 is joined 30.0ml PBS, among the 1X and antibody is diluted to 1: 30 in PBS, 000.
Homogeneity
In planning of experiments, intermediate value is comprised the homogeneity checking of MYCOSORB product (4.0kg/T) the acquisition sample of level.To repeat 5 times being determined on 10 independent samples of this specified level, each sample uses 4 to repeat (table 23).
The table 23. pair single concentration that is mixed in the pig feed material is the homogeneity evaluation of the MYCOSORB product of 4.0kg/T, and it carries out 5 BT(batch testing)s by the ELISA program to the independent sample preparation of 10 replicate analysis 4 times and estimates.
Proofread and correct
The feed that is mixed with known standard model concentration and the MYCOSORB product in 0.0 to 6.0kg/T scope is measured correction, use linearity curve match y=Ax (its intercept is arranged on zero place) limiting concentration and response (OD
450) between relation, be shown among Fig. 6 from the average curve of 5 BT(batch testing)s.
The linearity
By using best-fit line (the best-fit line intercept is at zero place) Δ OD after blank according to deduction
450What=Ax (MYCOSORB) drew comprises level to OD
450The equation of the figure line that absorbs calculates the linearity that regression coefficient is come the evaluation criterion curve.Be higher than r owing to find facies relationship numerical value
2>0.95 and the linearity of criterion of proof curve, the regression coefficient of each standard testing curve and average standard testing curve calculation is recorded in the table 24.
The linearity of table 24. pig feed material Plays curve.
Square error is defined as in linear regression model (LRM):
Wherein
y
iY value for measuring;
Expectation x for the MYCOSORB product
iThe theoretical value of concentration.
Repeatability
Repeatability is measuring by the inside variation of assessment repeatability standard deviation.By the reproducibility in the repetition that is obtained on the same day same BT(batch testing) by constructed librarian use identical device and method from the same sample of same BT(batch testing), to represent the detection variation C in the same BT(batch testing)
In(table 25).By not obtaining reproducibility between the different BT(batch testing)s by constructed librarian use identical device and method from the same sample of different BT(batch testing)s on the same day, to represent the detection variation CV between the different BT(batch testing)s
Between(table 26).
The result is presented on the same day and all has less variability at the typical curve that does not obtain on the same day, and when be applied to 0.0 and 6.0kg/T between the typical curve working range time average withinday precision be 7% and day to day precision be 20%.
Interior repeated precision is criticized in the test that table 25. typical curve makes up.
Repeated precision between the test that table 26. typical curve makes up is criticized.
The overall precision that table 27. typical curve makes up.
L
DAnd L
Q(sensitivity)
L
DAnd L
QValue record is in table 28.Find L
QThe recommendation that value is lower than the MYCOSORB product comprises rate, thereby makes it possible to this product in the feed material is carried out quantitatively.
Detectability L
D=0.403 ± 0.150kg/T
Quantitative limit L
Q=1.363 ± 0.498kg/T
The LD of table 28. pig feed material and LQ measure.
Accuracy
By 5 independent experiments (each experiment comprises 10 independent sample and each sample repeated test 4 times) to being mixed into the MYCOSORB product accuracy of measurement of the 4.0kg/T concentration in the feed material.The measured value that is used for homogeneity calculating that use as described herein obtains is calculated the ultimate density (table 29) of each sample.Then calculate average precision by the bat that all tests are obtained, and compare with the mark-on concentration amount 4.0kg/T that is mixed into the MYCOSORB product in the feed material.Carry out this calculating according to formula as herein described.
The result shows that it is that the mark-on concentration of MYCOSORB product is over-evaluated 20% (table 30) that recovery assessment causes real content to the feed material.
Accuracy and precision that table 29. is measured the MYCOSORB product that is mixed into the 4.0kg/T concentration in the feed material by 5 independent experiments (each experiment comprises 10 independent sample and each sample repeated test 4 times).
Table 30. is by 5 independent experiments overall recovery of on average the MYCOSORB product that is mixed into the 4.0kg/T concentration in the feed material being measured of (each experiment comprises 10 independent sample and each sample repeated test 4 times).
Use chicken and pig feed material identification
The feed ELISA that carries out detecting for MYCOSORB in chicken and pig matrix measures, and checking and compare with the result in the independent experiment chamber.At Alimetrics, Ltd., Koskelontie 19B, Espoo, Finland verify described mensuration.
At different 2 days the feed of the MYCOSORB product that is mixed with the known standard model concentration in 0.0 to 6.0kg/T scope is measured correction.Use linearity curve match y=Ax (intercept is arranged on zero place) to limit concentration and response (OD in pig feed raw material and the chicken feedstuff
450) between relation.Absorbance and gained are proofreaied and correct between the difference test is criticized significantly different; Yet it is identical that the absolute concentration of known sample and blind sample keeps.
The linearity
By using best-fit line (the best-fit line intercept is at zero place) Δ OD after blank according to deduction
450What=Ax (MYCOSORB) drew comprises level to OD
450The equation of the figure line that absorbs calculates the linearity that regression coefficient is come the evaluation criterion curve.Be higher than r owing to find facies relationship numerical value
2>0.95 and the linearity of criterion of proof curve, the related coefficient scope is 0.991 to 0.994 (table 31).
The linearity of table 31. chicken and pig feed material Plays curve.
Square error is defined as in linear regression model (LRM):
Wherein
y
iY value for measuring;
Expectation x for the MYCOSORB product
iThe theoretical value of concentration.
L
DAnd L
Q(sensitivity)
L
DAnd L
QValue is measured in 40% hydrochloric acid matrix.L separately
DAnd L
QThe estimation of value is respectively 0.35kg/T and the 1.20kg/T MYCOSORB that is mixed in the chicken feedstuff and is mixed into 0.27kg/T and 0.91kg/T MYCOSORB (respectively table 32 and table 33) in the pig feed raw material.
Table 32. carried out and by validation laboratory the chicken feedstuff is carried out two independent results of the blank samples of acquisition in the test batch in one time of interval.
Table 33. carried out and by validation laboratory the pig feed raw material is carried out two independent results of the blank samples of acquisition in the test batch in one time of interval.
Accuracy and the precision of " known " sample
By 2 independent experiments (comprising 6 replicate determinations) at every turn to being mixed into the MYCOSORB product accuracy of measurement of the 4.0kg/T concentration in the feed material.Calculate average precision by the bat that all tests are obtained, and compare with the mark-on concentration amount 4.0kg/T that is mixed into the MYCOSORB product in the feed material.
The value that obtains reaches the standard of accuracy and precision two aspects, and is as follows.
By the reproducibility in the repetition that is obtained on the same day same BT(batch testing) by constructed librarian use identical device and method from the same sample of same BT(batch testing), to represent the detection variation CV in the same BT(batch testing)
InBy not obtaining reproducibility between the different BT(batch testing)s by constructed librarian use identical device and method from the same sample of different BT(batch testing)s on the same day, to represent the detection variation CV between the different BT(batch testing)s
Between
Following for chicken and pig matrix, the value of acquisition reaches the standard (table 34 and table 35) of accuracy and precision two aspects.
Table 34. is mixed into the known sample (4.0kg/T) of the MYCOSORB product in the chicken feed material in accuracy and the precision of different 6 repeated tests mensuration of carrying out in 2 days by use.
Table 35. is mixed into the known sample (4.0kg/T) of the MYCOSORB product in the pig feed material in accuracy and the precision of different 6 repeated tests mensuration of carrying out in 2 days by use.
Accuracy and the precision of " the unknown " sample
In Blind Test by 2 independent experiments (comprising 3 replicate determinations) at every turn to being mixed into the MYCOSORB product accuracy of measurement of the 4.0kg/T concentration in the feed material.The value that obtains reaches the standard of accuracy and precision two aspects, following (table 36 and table 37).
Accuracy and precision that table 36. is measured by 3 repeated tests that the unknown sample (4.0kg/T) that is mixed into the MYCOSORB product in the chicken feed material is carried out.
Accuracy and precision that table 37. is measured by 3 repeated tests that the unknown sample (4.0kg/T) that is mixed into the MYCOSORB product in the pig feed material is carried out.
Anti-sex change
The ability of the assay of anti-sex change measuring method opposing results change when standing the subtle change of environment and program variable.
Stability by changing one-level antibody and secondary antibody dilutability, one-level antibody, study (the single plate vs. that comprises all samples to be determined and comprise blank, standard items and unknown sample comprises each analytic sample more multiple multiple but blank, standard items and a plurality of microtiter plates of unknown sample on different microtiter plates) stability of ELISA mensuration in the distribution on the microtiter plate by changing different testing samples.Table 38 has recorded variation, and show in addition in situation about changing the result also be consistent, this shows that this test has the stronger dilution variation of anti-sex change, especially antagonist.
The anti-sex change test of table 38..Standard conditions illustrate with runic.If exist, 10% change also highlights.
Embodiment 5
The monoclonal antibody specificity test
Method
Take the monoclonal antibody that produces for yeast (1 → 4)-α-D-glucosan/(1 → 6)-callose-BSA conjugate test 17 kinds in PBS concentration as the compound of 50 μ g/ml to determine cross reactivity.
The compound of test is: the solubility farina, rice starch, wheaten starch, cornstarch, BSA, glycogen (from rabbit), glycogen (from oyster), glycogen (ox), mannan, laminarin, Zymosin A, Maltrin QD, glucosan from Saccharomyces cerevisiae, (1 → 3)-callose from very thin Euglena (Eug.gracilis), torula (Torulayeast), the Ycw-02 of pearl mill device preparation (yeast cells wall part-pearl mill device preparation), beta glucan from barley.
Also tested concentration and be the yeast cell wall extract (MYCOSORB lot number 08FS001) of 1 μ g/ml, 2 μ g/ml and 5 μ g/ml and for generation of (1 → the 4)-α of monoclonal antibody-D-glucosan/(1 → 6)-callose-BSA antigen.Two kinds of monoclonal antibodies (513A161.1 and 513A431.1) are all measured with the dilutability of following scope: 1: 100,1: 200,1: 500,1: 1000,1: 1500 and 1: 2000.Use 96 hole Nunc microtiter plates of lot number 0702013.Each hole of plate is shaken for 8-10 time coated with 100 μ l compounds and by the tapping of use finger tip.Plate is covered with band and under 37 ℃, hatch 1h.The use multichannel pipettor removes solution and with plate washing 3 times, 200 μ l PBS are used in each washing.Before removing wash solution, use finger tip tapping plate 8-10 time at every turn.Between the washing, by plate tapping on paper handkerchief is removed unnecessary liquid.In order to seal, 3% milk (not centrifugal) of 100 μ l is added in each hole.Plate is at room temperature hatched 1h.Remove lock solution and use 1x 200 μ l PBS, 2x 200 μ lPBS+0.05% polysorbate20s to wash each hole.Before removing wash solution, pass through to use 8-10 swing plate of finger tip tapping at every turn.Between the washing, by plate tapping on paper handkerchief is removed unnecessary liquid.
Every kind of dilution suitable serum of 100 μ l is added in each hole.PBS (100 μ l/ hole) is used for blank well.Plate is covered, at room temperature hatches 1h.Remove solution and with each hole washing 3 times, use 200 μ l PBS+0.05% polysorbate20s at every turn.Before removing wash solution, use finger tip tapping plate 8-10 time to shake at every turn.Between the washing, by plate tapping on paper handkerchief is removed unnecessary liquid.100 μ l secondary antibody (1: 10,000 sheep anti mouse, the IgG-peroxidase conjugated) are added in each hole.Plate is covered, at room temperature hatches 1h.Remove solution and with each hole washing 3 times, wash use 200 μ l PBS+0.05% polysorbate20s at every turn.Before removing wash solution, use finger tip tapping plate 8-10 time to shake at every turn.Between the washing, by plate tapping on paper handkerchief is removed unnecessary liquid.
100 μ l room temperature tmb substrates are added in each hole.After 5 minutes, 100 μ l 1N HCl cessation reactions are used in each hole.Plate bottom fingerprint is cleaned, and after 10 seconds shakes, used the microtiter plate reading apparatus to read absorbance under the 450nm.
The result
The histogram of ELISA data is shown among Fig. 9-14.513A161.1 and 513A431.1 and concentration is low to moderate all very consumingly reactions of antigen 499-73-3 of 1 μ g/ml, and the absorbance reading the strongest with the generation of 2 μ g/ml antigen-reactives.Antibody also can be identified the 08FS001 of concentration in 1 μ g/ml to 5 μ g/ml scope, and has the strongest absorbance reading under 5ug/ml.Yet the absorbance of 08FS001 significantly is lower than antigen 499-73-3.Antibody 513A161.1 identification laminarin and reaction remarkable with it, and 513A431.1 is quite different.For Zymosin A, two kinds of antibody all have very strong absorbance reading, and this absorbance reading is similar to and sometimes is better than the absorbance that sees antigen 499-73-3.Surprisingly, described antibody demonstration and ZymosinA, Maltrin QD, from the glucosan of Saccharomyces cerevisiae, (1 → 3)-callose, torula and the sedimentary remarkable cross reaction of ycw-02 pearl mill device from very thin Euglena, be used for purposes that quantitative ELISA is measured thereby limited it.
Embodiment 6
Optimize monoclonal antibody ELISA condition determination to detect from the trial of the antigen of feed extraction
The dilution contrast is diluted in the PBS+3% skimmed milk power in PBS
In measuring, attempt quantitative ELISA using monoclonal antibody 513A161.1 (embodiment 5) to cause the low absorbance reading to detect the antigen that extracts from feed.In order to determine whether antibody dilution is affected absorbance reading (for example, by causing excessive sealing when the feed extract components is combined) in 3% milk (with respect to being diluted among the PBS), carry out following scheme:
Use as described in example 4 above the solution that comprises 0.5%HCl that yeast cell wall extract (MYCOSORB lot number 08FS001) is carried out the chemical extraction method.Carry out as described in example 5 above ELISA and measure, use dilutability be 1: 400 monoclonal antibody 513A161 as one-level antibody and the sheep anti-mouse igg that uses to be diluted in PBS or 3% milk-HRP antibody (1: 10,000) as secondary antibody.With each hole of microtiter plate coated with 100 μ l yeast cell wall extracts or each hole coated with 200 μ l by the extract that is diluted in PBS at 1: 1.
Be shown in result among Figure 15 confirm to observe the antibody dilution agent slightly but statistically inapparent impact.In addition, attempt to use monoclonal antibody detect three replications that the antigen (described antigen extracts with 0.5%HCl) in the forage standard product carries out cause between the replicate determination reading than great fluctuation process, larger standard deviation and the absorbance reading raised.
Antigen coating step-temperature and time
In measuring, attempt quantitative ELISA using monoclonal antibody 513A161.1 (embodiment 5) to cause the low absorbance reading to detect the antigen that extracts from feed.In order to improve the absorbance reading of the ELISA that uses mouse monoclonal antibody 513A161.1, carry out following experiment and apply time of incubation step and temperature and whether can improve the detection of the antigen that extracts from feed and not increase background/non-specific binding to determine to change antigen.
Scheme comprises that carrying out as mentioned above feed extracts to produce analytic sample.Sample aliquot is coated on the plate immediately or spends the night-25 ℃ of lower preservations.Repeat samples prepares 3 times to produce three Acetone parallel extracts.Use antigen in the chicken feed formulations prepare 6 typical curve samples (0,0.4,0.8,1.2,1.8,2.4kg/T).Plate is applied with feed extract typical curve sample and it is hatched under the following conditions: spend the night under 4 ℃ (static), spend the night (shaking) or 37 ℃ lower 1 hour (static) under 4 ℃.Carrying out as described in example 5 above ELISA measures, use the monoclonal antibody 513A161.1 that in 3% milk, prepares by 1: 400 dilutability to be diluted in sheep anti-mouse igg in 3% milk-HRP antibody (1: 10,000) as secondary antibody as one-level antibody and use.Substrate is hatched and is carried out 30 minutes, and measures the absorbance under the 450nm.
The result who is shown among Figure 16 shows: change antigen and be coated to the linearity that time on the plate and temperature can't increase to absorbance optimum range and also can not affect typical curve.In addition, background increases with incubation time irrelevant.
Embodiment 7
Polyclonal antibody selectivity (interference) test
In order to determine annoyance level, use chicken feed material as herein described to carry out one group of mensuration, described chicken feed material does not contain or contains the MYCOSORB product that amount is 1kg/T (reference number 285965), this chicken feed material that contains the MYCOSORB product does not contain or contain the carbohydrates that exists in the feed formulations belonging to of some ratios or the product that may disturb of secondary product, and (comprising level than the MYCOSORB product is 50%, 100%, 200%, w/w).In this respect, following product has been studied and has been tested to estimate it to passing through the really impact of blanking method detection MYCOSORB product of this paper:
Amylose (farina): (1 → 4): the ratio of (1 → 6)-α-D-glucosan is 30: 1.
Maltodextrin and corn-syrup solids: the digestible carbohydrates of appearance of being made by the polymkeric substance of native corn starch, dextrose.
Glycogen (from cattle liver, the IX type): (1 → 4): the ratio of (1 → 6)-α-D-glucosan is 10: 1.
Laminarin (from palmate sea-tangle (Laminaria digitata)): the ratio of (1 → 3): β (1 → 6)-callose is 3: 1.
Distiller's dried grain; Secondary product by the Maize Production bio-ethanol.
Red Star
The active dry wine yeast (from saccharomyces bayanus (Saccharomyces bayanus)) of Pasteur champagne: yeast is connected with yeast cell wall by (1 → 3): β (1 → 6)-callose, (1 → 4) that is connected with protein: (1 → 6)-α-D-gathers mannose, (1 → 2): the complex carbohydrate that (1 → 4)-β-N-Acetyl-D-glucosamine is made).
As shown in Fig. 7 and Fig. 8, use the MYCOSORB product and the difference that is mixed with between the signal of MYCOSORB product acquisition of interfering material of 50%, 100%, 200% (w/w) adds up to about 0 OD
450Value.This presentation of results do not exist disturb and therefore described mensuration for detection of the specificity of MYCOSORB product in the complicated feed substrate that comprises different carbohydrates interfering materials.
The detailed results of every kind of independent interfering material and one-way analysis of variance check provide to table 44 at table 39 in the ultimate value of 95% fiducial interval, have wherein calculated difference and standard deviation and the coefficient of variation of optical density (450nm) mean value and sample room.Homogeneity of variance in used Levene ' s, O ' Brien ' s and Brow and Forsythe test evaluation every kind of interfering material.In the situation of non-constant variance, use nonparametric Kruskal-Willis one-way analysis of variance method, wherein order conversion produces the check of and anti-exceptional value more sane to non-normality.For every kind of interfering material concentration of test, on different plates or in single independent plate, analyze.Two kinds of plates prepare identical result.
Be mixed with the OD that the MYCOSORB product of the amylose of 0,50%, 100%, 200% (w/w) obtains in the table 39. pair chicken feed
450Mean value.Difference between the value is that 95% one-way analysis of variance and average comparative statistics check are analyzed by fiducial interval.
Be mixed with the OD that the MYCOSORB product of the maltodextrin of 0,50%, 100%, 200% (w/w) obtains in the table 40. pair chicken feed
450Mean value.Difference between the value is that 95% one-way analysis of variance and average comparative statistics check are analyzed by fiducial interval.
Be mixed with the OD that the MYCOSORB product of the glycogen of 0,50%, 100%, 200% (w/w) obtains in the table 41. pair chicken feed
450Mean value.Difference between the value is that 95% one-way analysis of variance and average comparative statistics check are analyzed by fiducial interval.
Be mixed with the OD that the MYCOSORB product of the laminarin of 0,50%, 100%, 200% (w/w) obtains in the table 42. pair chicken feed
450Mean value.Difference between the value is that 95% one-way analysis of variance and average comparative statistics check are analyzed by fiducial interval.
Be mixed with the OD that the MYCOSORB product of the REDSTAR brewer yeast of 0,50%, 100%, 200% (w/w) obtains in the table 43. pair chicken feed
450Mean value.Difference between the value is that 95% one-way analysis of variance and average comparative statistics check are analyzed by fiducial interval.
Be mixed with the OD that the MYCOSORB product of the distiller's dried grain of 0,50%, 100%, 200% (w/w) obtains in the table 44. pair chicken feed
450Mean value.Difference between the value is that 95% one-way analysis of variance and average comparative statistics check are analyzed by fiducial interval.
All publications and the patent mentioned in the above-mentioned instructions all are incorporated herein by reference.Under the prerequisite that does not depart from the scope of the present invention with spirit, will be apparent for a person skilled in the art to various modifications and the change of described method and system of the present invention.Although the present invention is described in conjunction with concrete preferred embodiment, should be appreciated that the present invention who is subjected to claims protection should not be subjected to the restriction of these specific embodiments undeservedly.In fact, be used for implementing the various modification of described mode of the present invention, for carbohydrate chemistry, microbiology, animal feed and nutrition, immunology or those skilled in the relevant art, be apparent, and be intended to be included in the scope of following claims.
Claims (43)
1. method for detection of yeast cell wall in the sample comprises:
-sampling;
-with described sample be exposed to can in conjunction be selected from (1 → 4)-α-D-glucosan, (1 → 6)-callose and (1 → 4)-α-/the one-level antibody of the antigen of (1 → 6)-callose, thereby form the one-level Antibody-antigen complex; With
-use secondary antibody detects the combination degree between described one-level antibody and the described antigen.
2. method according to claim 1, wherein said analyte derivative is from being selected from following material: animal feeding-stuff, companion animals feed, feedstuff, total mixed ration (TMR), forage, feed granules, feed concentrate, feed pre-composition secondary product, cereal, vinasse, molasses, fiber, forage grass, herbage, hay, seed, blade, meal, solubility feed, feed additive, with and the preparation intermediate.
3. method according to claim 2, wherein said deriving realized to obtain described sample by extracting described material.
4. method according to claim 3, wherein said extraction are used and are selected from following step and carry out: acid extractants, alkali extractions, organic extraction, Physical Processing and make up.
5. method according to claim 4, wherein said extraction is with an organic solvent carried out with acid.
6. method according to claim 5, wherein said extraction use dimethyl sulfoxide (DMSO) and hydrochloric acid to carry out.
7. method according to claim 4, wherein said extraction step also is included under the temperature that is higher than room temperature and hatches.
8. method according to claim 7, wherein said being incubated between 75 ℃ and 85 ℃ carried out.
9. method according to claim 1, wherein said one-level antibody is special to described antigen list.
10. method according to claim 1, wherein said one-level antibody is polyclonal antibody.
11. method according to claim 1, the described combination degree that wherein detects between described antibody and the described antigen carries out under secondary antibody auxiliary, described secondary antibody be conjugated to and be selected from enzyme, fluorescent material, add lustre to material and the isotopic material of radioactive label.
12. method according to claim 1, wherein said secondary antibody can with described one-level antibody complex formation.
13. method according to claim 1, wherein said sample is fixed on the rigid support thing.
14. method according to claim 13, wherein said rigid support thing comprises multiple-plate hole.
15. method according to claim 1, the described detection of the combination between wherein said one-level antibody and the described antigen by determine with described sample in realize in conjunction with the level that has corresponding signal of the described secondary antibody of described one-level Antibody-antigen complex.
16. method according to claim 15, wherein said signal are selected from the signal that adds lustre to, fluorescence signal, based on the molecule of size detection, molecule, radiation and isotope signal based on absorbance detection.
17. method according to claim 1, wherein said detection use the ELISA immunoassays to carry out.
18. the method for the preparation of the immunogenic composition that comprises the yeast cell wall carbohydrates comprises:
-sample that comprises yeast cell wall is provided;
-use the action that is selected from acid treatment, alkali treatment and physical treatment from described sample, to extract described yeast cell wall carbohydrates; With
-from the described yeast cell wall carbohydrates of described sample separation, wherein said yeast cell wall carbohydrates for be selected from (1 → 4)-α-D-glucosan, (1 → 6)-callose and (1 → 4)-α-/carbohydrates of (1 → 6)-callose.
19. method according to claim 18, wherein said extraction use acid treatment to carry out.
20. method according to claim 19, wherein said acid are hydrochloric acid.
21. method according to claim 18 also comprises the yeast cell wall carbohydrates of the described separation of purifying.
22. method according to claim 21, wherein said purifying is realized by being selected from following step: based on the size separation, based on charge separation, based on the hydrophobicity separation, based on the affinity of binding molecule is separated and separated based on molecular conformation.
23. method according to claim 18 also comprises the yeast cell wall carbohydrates of the described separation of mixed oxidization.
24. method according to claim 23, wherein said mild oxidation is by using oxidizer treatment to realize.
25. method according to claim 24, wherein said mild oxidation realizes by using dimethyl sulfoxide (DMSO) and acetic anhydride to process described yeast cell wall carbohydrates.
26. method according to claim 24, wherein said mild oxidation cause activating described yeast cell wall carbohydrates.
27. method according to claim 26, wherein said activation is carried out in the C6 position of described yeast cell wall carbohydrates.
28. method according to claim 26, wherein said activation causes forming aldehyde radical.
29. method according to claim 26 comprises also that yeast cell wall carbohydrates with described activation is exposed to be selected from following carrier molecule: bovine serum albumin(BSA), keyhole relative hemocyanin, ovalbumin and bovine thyroglobulin.
30. method according to claim 29, wherein said carrier molecule are bovine serum albumin(BSA).
31. an immunogenic composition, comprise (1 → the 4)-α covalently bound with protein-/(1 → 6)-callose.
32. immunogenic composition according to claim 31, wherein said composition is produced by the saccharomyces cerevisiae biosome.
33. immunogenic composition according to claim 31, wherein said covalent bonding occurs by the C6 atom of described carbohydrates.
34. a composition, comprise can in conjunction be selected from (1 → 4)-α-D-glucosan, (1 → 6)-callose and (1 → 4)-α-/antibody of the yeast cell wall carbohydrates of (1 → 6)-callose.
35. antibody according to claim 34, wherein said antibody are monoclonal antibody.
36. antibody according to claim 34, wherein said antibody are polyclonal antibody.
37. antibody according to claim 34, wherein said antibody can be in conjunction with (1 → 4)-α-D-glucosan.
38. antibody according to claim 34, wherein said antibody can be in conjunction with (1 → 6)-callose.
39. one kind for the preparation of being used for the method for yeast cell wall in the test sample, comprises and use immunogenic composition immunity host animal according to claim 31.
40. the kit for detection of yeast cell wall in the sample comprises:
-be used for the reagent of extraction step, described extraction step cause discharging be selected from (1 → 4)-α-D-glucosan, (1 → 6)-callose and (1 → 4)-α-/the yeast cell wall carbohydrates of (1 → 6)-callose; With
Thereby-can be combined in the one-level antibody of the described yeast cell wall carbohydrates formation one-level Antibody-antigen complex of described extraction step extraction; With
Thereby-can be attached to the secondary antibody that described one-level Antibody-antigen complex forms one-level antibody-antigen-bivalent antibody compound.
41. described kit according to claim 40, thus described secondary antibody be conjugated to and be selected from enzyme, fluorescent material, add lustre to material and the isotopic material of radioactive label.
42. a method that is used for the existence of definite sample yeast cell wall fraction, described method comprises:
-sampling;
-described sample is carried out immunologic assay, wherein said mensuration detect be selected from (1 → 4)-α-D-glucosan, (1 → 6)-callose and (1 → 4)-α-/the described existence of the compound of (1 → 6)-callose; With
The result of the described mensuration of-transmission.
43. described method according to claim 42, wherein said analyte derivative is from being selected from following material: animal feeding-stuff, companion animals feed, feedstuff, total mixed ration (TMR), forage, feed granules, feed concentrate, feed pre-composition secondary product, cereal, vinasse, molasses, fiber, forage grass, herbage, hay, seed, blade, meal, solubility feed, feed additive, with and the preparation intermediate.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33499510P | 2010-05-14 | 2010-05-14 | |
US61/334,995 | 2010-05-14 | ||
PCT/US2011/036518 WO2011143613A1 (en) | 2010-05-14 | 2011-05-13 | Yeast cell wall components and detection thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102939537A true CN102939537A (en) | 2013-02-20 |
CN102939537B CN102939537B (en) | 2016-09-14 |
Family
ID=44912110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180029236.2A Active CN102939537B (en) | 2010-05-14 | 2011-05-13 | Yeast cell wall fraction and detection thereof |
Country Status (25)
Country | Link |
---|---|
US (1) | US20110281283A1 (en) |
EP (1) | EP2569632B1 (en) |
JP (1) | JP2013532276A (en) |
KR (1) | KR101440818B1 (en) |
CN (1) | CN102939537B (en) |
AU (1) | AU2011252840B2 (en) |
BR (1) | BR112012030535B1 (en) |
CA (1) | CA2798328A1 (en) |
CL (1) | CL2012003165A1 (en) |
CO (1) | CO6660470A2 (en) |
DK (1) | DK2569632T3 (en) |
EA (1) | EA201291091A1 (en) |
ES (1) | ES2691260T3 (en) |
IL (1) | IL222789A (en) |
MX (1) | MX2012013170A (en) |
MY (1) | MY173081A (en) |
NZ (2) | NZ603340A (en) |
PE (1) | PE20130526A1 (en) |
PL (1) | PL2569632T3 (en) |
PT (1) | PT2569632T (en) |
RS (1) | RS57937B1 (en) |
SG (1) | SG185485A1 (en) |
UA (1) | UA103283C2 (en) |
WO (1) | WO2011143613A1 (en) |
ZA (1) | ZA201208200B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105137084A (en) * | 2015-08-20 | 2015-12-09 | 厦门大学 | Glucan sandwich enzyme-linked immunosorbent assay method |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10392639B2 (en) | 2014-03-21 | 2019-08-27 | Dsm Ip Assets B.V. | Process for the treatment of yeast cell walls with a laminaripentaose producing beta-1,3-glucanase |
CN107709348A (en) * | 2015-05-08 | 2018-02-16 | 沃特世科技公司 | For extracting the composition and method of mycotoxin |
JP6530846B1 (en) * | 2018-10-09 | 2019-06-12 | アサヒグループホールディングス株式会社 | Immunostimulatory agent and method for preventing infection |
CN114196216B (en) * | 2021-12-27 | 2023-01-06 | 杭州靡特洛新材料科技有限公司 | Full-biodegradable thermoplastic water-soluble film based on vinasse waste and preparation method and application thereof |
CN117126753B (en) * | 2023-10-26 | 2024-04-09 | 中粮营养健康研究院有限公司 | Saccharomyces cerevisiae for producing polysaccharide and application thereof in longan wine brewing |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101111523A (en) * | 2004-10-18 | 2008-01-23 | 进取生物活性有限公司 | Process for producing natural immunobiotic extract and uses thereof |
CN101353383A (en) * | 2008-09-17 | 2009-01-28 | 山东京博控股发展有限公司 | Water-soluble yeast beta-dextran and preparation thereof |
CN101403749A (en) * | 2008-11-17 | 2009-04-08 | 北京大学 | Reagent kit for auxiliary diagnosis of autoimmune disease through glucosan specificity antibody |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69228247T2 (en) | 1991-08-10 | 1999-07-08 | Medical Research Council, London | Treatment of cell populations |
EP0672142B1 (en) | 1992-12-04 | 2001-02-28 | Medical Research Council | Multivalent and multispecific binding proteins, their manufacture and use |
PL177628B1 (en) * | 1993-08-06 | 1999-12-31 | As Biotec Mackzymal | Yeast glycane containing animal fodder |
DE4402065A1 (en) * | 1994-01-25 | 1995-09-07 | Behringwerke Ag | Saccharomyces specific antigens and antibodies, their production and use |
US6214337B1 (en) * | 1995-04-18 | 2001-04-10 | Biotec Asa | Animal feeds comprising yeast glucan |
ATE312194T1 (en) * | 1998-04-17 | 2005-12-15 | Biotrex S R L | PRODUCT BASED ON POLYSACCHARIDES FROM BAKER YEAST AND ITS USE AS AN ADDITIVE FOR BAKED PRODUCTS |
EP1234886A1 (en) * | 2001-02-23 | 2002-08-28 | Universiteit van Amsterdam | A method for detecting beta-1,6-glucan synthase activity |
GB0211118D0 (en) * | 2002-05-15 | 2002-06-26 | Polonelli Luciano | Vaccines |
CA2543939C (en) * | 2003-10-31 | 2014-05-13 | Immunetics, Inc. | Rapid peptidoglycan-based assay for detection of bacterial contamination of platelets |
US20080102486A1 (en) * | 2006-10-27 | 2008-05-01 | Horgan Karina A | Method for detection of yeast cell wall |
NZ577206A (en) * | 2006-12-14 | 2012-03-30 | Archer Daniels Midland Co | Animal feeds containing polyols |
JP5054425B2 (en) * | 2007-05-07 | 2012-10-24 | 尚仁 大野 | Anti-β-1,6-glucan monoclonal antibody |
-
2011
- 2011-05-13 JP JP2013510349A patent/JP2013532276A/en active Pending
- 2011-05-13 CA CA2798328A patent/CA2798328A1/en not_active Abandoned
- 2011-05-13 WO PCT/US2011/036518 patent/WO2011143613A1/en active Application Filing
- 2011-05-13 PE PE2012002163A patent/PE20130526A1/en not_active Application Discontinuation
- 2011-05-13 KR KR1020127032098A patent/KR101440818B1/en active IP Right Grant
- 2011-05-13 EA EA201291091A patent/EA201291091A1/en unknown
- 2011-05-13 PT PT11781379T patent/PT2569632T/en unknown
- 2011-05-13 NZ NZ603340A patent/NZ603340A/en unknown
- 2011-05-13 SG SG2012082491A patent/SG185485A1/en unknown
- 2011-05-13 AU AU2011252840A patent/AU2011252840B2/en active Active
- 2011-05-13 MY MYPI2012004906A patent/MY173081A/en unknown
- 2011-05-13 RS RS20181309A patent/RS57937B1/en unknown
- 2011-05-13 DK DK11781379.0T patent/DK2569632T3/en active
- 2011-05-13 EP EP11781379.0A patent/EP2569632B1/en active Active
- 2011-05-13 CN CN201180029236.2A patent/CN102939537B/en active Active
- 2011-05-13 US US13/107,716 patent/US20110281283A1/en not_active Abandoned
- 2011-05-13 BR BR112012030535-2A patent/BR112012030535B1/en active IP Right Grant
- 2011-05-13 PL PL11781379T patent/PL2569632T3/en unknown
- 2011-05-13 ES ES11781379.0T patent/ES2691260T3/en active Active
- 2011-05-13 NZ NZ623714A patent/NZ623714A/en unknown
- 2011-05-13 UA UAA201213087A patent/UA103283C2/en unknown
- 2011-05-13 MX MX2012013170A patent/MX2012013170A/en unknown
-
2012
- 2012-10-31 ZA ZA2012/08200A patent/ZA201208200B/en unknown
- 2012-11-01 IL IL222789A patent/IL222789A/en active IP Right Grant
- 2012-11-12 CL CL2012003165A patent/CL2012003165A1/en unknown
- 2012-12-12 CO CO12225402A patent/CO6660470A2/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101111523A (en) * | 2004-10-18 | 2008-01-23 | 进取生物活性有限公司 | Process for producing natural immunobiotic extract and uses thereof |
CN101353383A (en) * | 2008-09-17 | 2009-01-28 | 山东京博控股发展有限公司 | Water-soluble yeast beta-dextran and preparation thereof |
CN101403749A (en) * | 2008-11-17 | 2009-04-08 | 北京大学 | Reagent kit for auxiliary diagnosis of autoimmune disease through glucosan specificity antibody |
Non-Patent Citations (6)
Title |
---|
D. ZEKOVIĆ等: "Mild Pfitzner-Moffat oxidation of the (1→3)-β-D-glucan from Saccharomyces cerevisiae", 《CHEMICAL PAPERS》 * |
HENRIETTE BRUSSAARD: "Novel ingredients protect animals from mycotoxins", 《FEED MIX》 * |
NAOHITO OHNO等: "Solubilization of yeast cell-wall β-(1→3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction", 《CARBOHYDRATE RESEARCH》 * |
STEFAN KWIATKOWSKI等: "A Study of Saccharomyces cerevisiae Cell Wall Glucans", 《JOURNAL OF THE INSTITUTE OF BREWING》 * |
戚荣 等: "抗葡聚糖单克隆抗体制备的研究", 《甘蔗糖业》 * |
曾练强 等: "葡聚糖多克隆抗体制备与纯化", 《广西轻工业》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105137084A (en) * | 2015-08-20 | 2015-12-09 | 厦门大学 | Glucan sandwich enzyme-linked immunosorbent assay method |
Also Published As
Publication number | Publication date |
---|---|
PL2569632T3 (en) | 2019-02-28 |
PT2569632T (en) | 2018-11-20 |
US20110281283A1 (en) | 2011-11-17 |
WO2011143613A1 (en) | 2011-11-17 |
MY173081A (en) | 2019-12-25 |
AU2011252840B2 (en) | 2014-07-03 |
KR101440818B1 (en) | 2014-11-03 |
EP2569632B1 (en) | 2018-08-15 |
PE20130526A1 (en) | 2013-05-05 |
CO6660470A2 (en) | 2013-04-30 |
CA2798328A1 (en) | 2011-11-17 |
ES2691260T3 (en) | 2018-11-26 |
CL2012003165A1 (en) | 2013-09-23 |
EP2569632A1 (en) | 2013-03-20 |
BR112012030535A2 (en) | 2018-01-16 |
KR20130038863A (en) | 2013-04-18 |
ZA201208200B (en) | 2014-01-29 |
MX2012013170A (en) | 2013-01-17 |
UA103283C2 (en) | 2013-09-25 |
NZ603340A (en) | 2014-04-30 |
RS57937B1 (en) | 2019-01-31 |
CN102939537B (en) | 2016-09-14 |
JP2013532276A (en) | 2013-08-15 |
SG185485A1 (en) | 2012-12-28 |
EA201291091A1 (en) | 2013-05-30 |
DK2569632T3 (en) | 2018-11-19 |
NZ623714A (en) | 2015-10-30 |
EP2569632A4 (en) | 2014-01-08 |
BR112012030535B1 (en) | 2021-06-01 |
IL222789A (en) | 2016-09-29 |
IL222789A0 (en) | 2012-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102939537B (en) | Yeast cell wall fraction and detection thereof | |
CN101865924B (en) | Method for detecting fumonisins based on immuno-magnetic bead combined enzyme-linked immunosorbent assay | |
CN102955031B (en) | Enzyme-linked immunosorbent assay kit for detecting aflatoxin B1-containing medicine and application for same | |
Pei et al. | Development of anti-zearalenone monoclonal antibody and detection of zearalenone in corn products from China by ELISA | |
CN101592661B (en) | Brucellosis antibody competitive enzyme-linked immunosorbent assay reagent kit | |
AU2011252840A1 (en) | Yeast cell wall components and detection thereof | |
CN101581726A (en) | New-generation brucellosis antibody competition enzyme-linked immunosorbent adsorption test detection kit | |
CN102746403A (en) | Standard substance universal alternate for aflatoxin detection by using ELISA, preparation method thereof, and ELISA detection method for aflatoxin | |
CN102967709A (en) | Enzyme linked immunosorbent assay kit for detecting zearalenone drug and application thereof | |
Maragos et al. | Development and evaluation of monoclonal antibodies for the glucoside of T-2 toxin (T2-Glc) | |
CN102080067B (en) | Method for detecting deoxynivalenol and special reagent kit thereof | |
CN101592660B (en) | Brucellosis indirect enzyme-linked immunosorbent assay milk liquid antibody reagent kit | |
CN106496323B (en) | Cluster-selective ochratoxin artificial antigen and preparation method of broad-spectrum polyclonal antibody thereof | |
CN102617516B (en) | The antibody of a kind of salbutamol artificial antigen and preparation thereof | |
CN101782579B (en) | Enzyme-linked immunoassay kit for detecting tiamulin medicaments, and application thereof | |
CN103288661A (en) | Preparation method and application of malachite green hapten | |
DE19842609C2 (en) | Salmonella antigen mixture and kit for the determination of antibodies against Salmonella | |
CN102608317B (en) | Kit or test strips for detecting salbutamol | |
AU2014240251A1 (en) | Yeast cell wall components and detection thereof | |
CN105372419B (en) | The preparation method and its application in quantum dot immune fluorescent kit of chloramphenicol haptens and antigen | |
Galvidis et al. | Monoclonal antibody-based enzyme-linked immunosorbent assay for the aminoglycoside antibiotic kanamycin in foodstuffs | |
Maragos et al. | Development of antibodies for N-(1-deoxy-D-fructos-1-yl) fumonisin B1 and cross-reaction with modified fumonisins | |
CN109959786A (en) | Avermectin/angstrom general rhzomorph/ivermectin three-in-one detection reagent box | |
CN105759040A (en) | Enzyme-linked immunosorbent reagent kit for detecting chloramphenicol residues | |
Henderson | Development of a novel monoclonal antibody-based immunoaffinity column for the detction of aflatoxins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |